Other antidepressants

OTHER_ANTIDEPRESSANTS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — N06AX 1 out of 7 registries used, show all original rules.	95756
4. Check minimum number of events Min. number of events 3	95756
5. Include endpoints None	95756
6. Filter based on genotype QC (FinnGen only)	95756

Control definitions (FinnGen only)

Control exclude: ANTIDEPRESSANTS

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	OTHER_ANTIDEPRESSANTS
CONTROL_EXCLUDE	ANTIDEPRESSANTS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	N06AX
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other antidepressants based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Copper deficiency

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	95756	61763	33993
Unadjusted period prevalence (%)	18.90	21.05	14.99
Median age at first event (years)	49.05	47.54	51.80

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
16239: Matched controls
100601

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N05CF01

ATC

zopiclone; oral

5.4

323.0

7442

13714

F32

ICD-10 Finland

Depressive episode

23.3

323.0

996

281

P01

ICPC

Feeling anxious/nervous/tense

4.6

323.0

1632

2378

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

57.7

323.0

981

112

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

5.4

323.0

1759

2226

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

23.3

323.0

1865

556

N06AB03

ATC

fluoxetine; oral

21.0

323.0

2651

926

P03

ICPC

Feeling depressed

8.0

323.0

1697

1451

N05AA02

ATC

levomepromazine; systemic

9.5

323.0

1022

706

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.9

323.0

2482

4397

P06

ICPC

Sleep disturbance

4.1

323.0

1666

2756

SPAT1240

SPAT

Therapeutic discussion

5.6

323.0

1762

2122

N05AH03

ATC

olanzapine; systemic

12.7

323.0

1474

786

N03AG01

ATC

valproic acid; systemic, rectal

5.7

323.0

1111

1278

N05BA12

ATC

alprazolam; oral

9.3

323.0

1932

1434

N05AX12

ATC

aripiprazole; systemic

13.4

323.0

698

336

N06AX21

ATC

duloxetine; oral

33.2

323.0

2844

638

N06CA01

ATC

amitriptyline and psycholeptics; systemic

6.0

323.0

1564

1748

N05AX08

ATC

risperidone; systemic

6.3

323.0

2134

2346

N05BA06

ATC

lorazepam; systemic, sublingual

6.7

323.0

1182

1160

F32.9

ICD-10 Finland

Depressive episode, unspecified

21.4

323.0

3211

1146

N06AG02

ATC

moclobemide; oral

26.8

323.0

1014

249

N06AX03

ATC

mianserin; oral

34.6

323.0

1706

340

N05CD07

ATC

temazepam; oral

5.3

323.0

3326

4685

N07BB01

ATC

disulfiram; oral

9.6

323.0

965

659

T36

ICD-10 Finland

Poisoning by systemic antibiotics

11.7

323.0

871

483

A06AC01

ATC

ispaghula (psylla seeds); oral

2.5

323.0

3394

9607

N05BA01

ATC

diazepam; systemic, rectal

4.9

323.0

2678

3918

N06AX12

ATC

bupropion; oral

81.1

323.0

1617

137

N05BA04

ATC

oxazepam; oral

8.7

323.0

6024

6392

R53

ICD-10 Finland

Malaise and fatigue

3.0

323.0

3669

9003

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

15.0

323.0

791

343

F34.1

ICD-10 Finland

Dysthymia

37.1

323.0

683

119

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

6.1

323.0

1720

1911

N06AA12

ATC

doxepin; systemic

16.2

323.0

1188

487

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

59.0

323.0

685

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

9.8

323.0

1300

888

F32.1

ICD-10 Finland

Moderate depressive episode

15.8

323.0

927

383

N06AB06

ATC

sertraline; oral

31.0

323.0

2381

553

F51.0

ICD-10 Finland

Nonorganic insomnia

7.8

323.0

2438

2237

N06AA09

ATC

amitriptyline; systemic

7.4

323.0

1609

1470

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

42.0

323.0

1755

289

N03AX09

ATC

lamotrigine; oral

14.4

323.0

772

348

N03AE01

ATC

clonazepam; systemic

6.8

323.0

1127

1086

A02BC02

ATC

pantoprazole; systemic

2.2

323.0

9492

39602

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

16.7

323.0

636

245

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

9.5

323.0

1588

1130

F41.1

ICD-10 Finland

Generalized anxiety disorder

12.8

323.0

757

382

N03AX12

ATC

gabapentin; oral

3.5

323.0

2505

5013

N06AX16

ATC

venlafaxine; oral

91.9

323.0

4343

398

N03AX16

ATC

pregabalin; oral

3.4

323.0

3899

8600

N05BE01

ATC

buspirone; oral

24.4

323.0

669

177

P76

ICPC

Depressive disorder

22.3

323.0

1217

364

N06AX26

ATC

vortioxetine; oral

85.6

323.0

1842

150

N02BE01

ATC

paracetamol; systemic, rectal

2.7

323.0

13129

61574

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

46.3

323.0

542

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

8.6

323.0

1654

1306

N06AX11

ATC

mirtazapine; oral

61.2

323.0

12685

5549

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

114.2

323.0

906

N05AH04

ATC

quetiapine; oral

13.7

323.0

4948

3125

N06AB04

ATC

citalopram; systemic

18.4

323.0

4709

2189

C07AA05

ATC

propranolol; systemic

3.8

323.0

2718

5053

N06AX05

ATC

trazodone; oral

56.5

323.0

606

N06AB05

ATC

paroxetine; oral

26.4

323.0

970

241

N06AB10

ATC

escitalopram; oral

25.5

323.0

4446

1465

N05CF02

ATC

zolpidem; oral

6.0

323.0

3044

3717

N06AX22

ATC

agomelatine; oral

177.1

323.0

471

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

32.8

318.9

493

N02AX02

ATC

tramadol; systemic, rectal

2.0

316.4

6533

25533

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.1

307.3

4886

17124

N06AB08

ATC

fluvoxamine; oral

29.9

302.9

478

102

N06AA06

ATC

trimipramine; systemic

26.2

300.1

489

119

AA1AD

NOMESCO Finland

CT of head and brain

2.2

297.4

4279

14319

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

290.4

6150

24038

A06AD11

ATC

lactulose; oral

2.4

288.2

2973

8448

A02BC05

ATC

esomeprazole; systemic

2.0

287.8

5274

19477

J01DB01

ATC

cefalexin; oral

1.9

279.3

11982

59718

N05AB03

ATC

perphenazine; systemic, rectal

10.2

275.0

633

398

G04CA02

ATC

tamsulosin; oral

1.9

270.4

6952

28906

N05AF03

ATC

chlorprothixene; systemic

15.5

264.1

506

208

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

14.4

259.3

511

226

M54.5

ICD-10 Finland

Low back pain

2.1

256.6

3995

13677

A28

ICPC

Limited function/disability NOS

2.3

254.9

2883

8528

M03BX02

ATC

tizanidine; oral

1.8

253.7

6874

28886

N05BA02

ATC

chlordiazepoxide; systemic

9.7

253.4

599

396

P29

ICPC

Psychological sympt/compl other

5.4

250.6

874

1042

F40.1

ICD-10 Finland

Social phobias

15.1

247.3

478

201

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

247.1

4639

17068

F29

ICD-10 Finland

Unspecified nonorganic psychosis

7.7

245.3

663

554

P74

ICPC

Anxiety disorder/anxiety state

10.1

241.6

560

356

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

9.0

241.0

594

424

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

240.4

3167

10040

N02AA05

ATC

oxycodone; systemic

2.3

239.2

2736

8111

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

45.5

237.9

345

L28

ICPC

Limited function/disability (L)

2.3

235.7

2627

7682

R07.4

ICD-10 Finland

Chest pain, unspecified

2.0

231.1

4119

14783

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

230.2

4395

16185

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

12.4

229.8

481

246

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

42.5

229.0

336

P20

ICPC

Memory disturbance

2.4

224.7

2394

6829

SPAT1307

SPAT

Psychosocial counselling and guidance

4.2

223.6

1007

1576

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

75.4

221.7

299

F10.20

ICD-10 Finland

Alcohol dependence currently independent

12.3

218.3

459

237

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

14.1

217.8

432

194

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.2

215.4

2596

7851

A04

ICPC

Weakness/tiredness general

2.4

214.2

2147

5920

G47.3

ICD-10 Finland

Sleep apnoea

2.1

213.4

3228

10794

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

12.9

211.9

436

214

A02BC01

ATC

omeprazole; systemic

1.9

211.6

4085

15018

P15

ICPC

Chronic alcohol abuse

7.6

210.8

573

482

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

49.8

210.1

300

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.8

206.7

1595

3778

N06AA04

ATC

clomipramine; systemic

44.6

204.2

297

N05AN01

ATC

lithium; oral

13.1

202.6

414

200

SPAT1301

SPAT

No procedures

1.8

202.1

5092

20451

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.9

200.7

4039

15020

A02BC03

ATC

lansoprazole; oral

1.9

199.5

3973

14715

R42

ICD-10 Finland

Dizziness and giddiness

2.0

195.8

3115

10584

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

171.6

195.2

245

N06DX01

ATC

memantine; oral

2.9

194.1

1377

3083

M79.6

ICD-10 Finland

Pain in limb

1.8

193.9

4338

16699

R03AC02

ATC

salbutamol; inhalant

1.7

188.7

6624

29254

WX110

NOMESCO Finland

Local anesthesy

1.6

188.6

9256

44851

R06.0

ICD-10 Finland

Dyspnoea

1.9

188.5

3727

13720

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

188.1

4665

18544

SPAT1254

SPAT

Administration of medicine

2.1

188.0

2820

9333

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

187.9

8851

42390

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

187.9

4771

19109

C07AB07

ATC

bisoprolol; oral

1.7

186.6

7626

35105

R51.80

ICD-10 Finland

Headache

2.5

183.2

1676

4372

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

181.5

6855

30789

SPAT1216

SPAT

Assessment of functional ability

2.1

179.7

2563

8291

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.8

177.1

4558

18258

M01AE01

ATC

ibuprofen; systemic, rectal

1.7

176.5

12107

63690

SPAT1234

SPAT

Support of social functional capacity

3.5

176.1

967

1790

J01CA04

ATC

amoxicillin; systemic

1.7

175.5

11449

59312

IGY02

NOMESCO Finland

Psychiatric monitoring contact

12.0

174.6

371

196

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

10.5

173.6

392

236

SPAT1263

SPAT

Sampling

1.7

173.5

6220

27424

A98

ICPC

Health maint/preventive medicine

1.9

171.5

13819

75941

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

11.3

168.1

366

204

N06AX18

ATC

reboxetine; oral

78.1

166.8

224

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

166.8

2513

8291

IGY99

NOMESCO Finland

Other psychiatric treatment contact

14.8

166.7

324

138

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

25.0

166.5

274

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

164.2

4853

20170

N04BC05

ATC

pramipexole; oral

3.1

164.0

1080

2290

L03

ICPC

Low back symptom/complaint

1.9

160.5

2829

9903

J01AA02

ATC

doxycycline; systemic

1.6

160.4

10049

50787

J01MA02

ATC

ciprofloxacin; systemic

1.6

160.2

5958

26361

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

159.6

8850

43356

F33

ICD-10 Finland

Recurrent depressive disorder

52.3

158.9

225

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.5

157.2

1445

3764

SPAT1243

SPAT

Psychiatric/psychological examination

7.0

157.2

449

407

F10.25

ICD-10 Finland

Alcohol dependence continuous use

8.9

155.9

383

271

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.9

155.8

1140

2590

M01AB05

ATC

diclofenac; systemic, rectal

1.6

155.2

8053

38687

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

14.4

154.8

304

133

M48.0

ICD-10 Finland

Spinal stenosis

2.2

154.5

1937

5889

F32.0

ICD-10 Finland

Mild depressive episode

9.8

154.3

361

233

N05AL01

ATC

sulpiride; systemic

17.3

154.1

283

103

N06AX17

ATC

milnacipran; oral

233.3

151.6

187

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

13.3

151.2

307

146

F61.0

ICD-10 Finland

Mixed personality disorders

27.3

151.1

243

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

47.0

150.7

217

SPAT1053

SPAT

Memory test

1.9

150.7

2879

10352

N05AF01

ATC

flupentixol; systemic

16.9

150.7

279

104

A02BA02

ATC

ranitidine; systemic

1.9

148.2

2830

10166

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

147.6

5429

23805

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

15.6

147.0

280

113

F41.09

ICD-10 Finland

UNS Panic Syndrome

9.6

144.5

341

224

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

11.6

143.3

308

167

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

18.9

142.9

255

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.5

142.7

1337

3511

P99

ICPC

Psychological disorders other

8.3

142.2

365

279

K02.1

ICD-10 Finland

Caries of dentine

1.6

142.1

7119

33622

F10.24

ICD-10 Finland

Alcohol depence active use

12.1

140.6

297

155

M01AC06

ATC

meloxicam; systemic, rectal

1.7

140.0

3824

15383

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.2

139.6

1756

5329

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

139.3

4893

21109

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.7

138.7

1140

2777

UJF32

NOMESCO Finland

Coloscopy

1.7

138.7

3695

14746

SPAT1229

SPAT

Assessment of need for aid

2.5

138.6

1285

3353

AA400

NOMESCO Finland

Electroconvulsive therapy

77.2

137.7

185

F32.8

ICD-10 Finland

Other depressive episodes

17.5

136.6

250

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

136.5

3347

13013

N06DA02

ATC

donepezil; oral

2.7

135.1

1104

2680

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.6

134.5

1140

2825

M01AE02

ATC

naproxen; oral, rectal

1.5

134.4

6966

33006

G04CA01

ATC

alfuzosin; oral

1.8

134.3

3177

12208

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.5

133.8

6465

30121

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

35.0

132.3

201

N40

ICD-10 Finland

Hyperplasia of prostate

1.5

131.8

6178

28548

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.7

130.3

1020

2411

F51

ICD-10 Finland

Nonorganic sleep disorders

6.7

129.6

381

360

R01AD09

ATC

mometasone; nasal

1.6

128.6

4656

20151

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

19.6

127.8

225

F99

ICD-10 Finland

Mental disorder, not otherwise specified

10.1

127.8

293

182

M54.4

ICD-10 Finland

Lumbago with sciatica

2.1

127.0

1629

4974

V03AA01

ATC

7.0

126.3

360

325

G04BD12

ATC

mirabegron; oral

2.2

126.0

1547

4632

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.0

126.0

1915

6279

M03BC51

ATC

orphenadrine, combinations; systemic

1.8

125.4

2599

9542

M03BC01

ATC

orphenadrine (citrate); systemic

1.9

125.1

2126

7273

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

125.0

5605

25531

C03CA01

ATC

furosemide; systemic

1.6

124.7

5205

23302

M01AH05

ATC

etoricoxib; oral

1.5

123.8

6188

28890

S18

ICPC

Laceration/cut

1.5

123.1

6099

28406

A01

ICPC

Pain general/multiple sites

2.7

122.6

995

2401

F41.8

ICD-10 Finland

Other specified anxiety disorders

8.5

122.5

308

227

K59.09

ICD-10 Finland

Constipation, unspecified

2.6

121.8

1038

2578

XKD00

NOMESCO Finland

Uroflowmetry

1.6

121.6

4162

17697

P01AB01

ATC

metronidazole; oral, rectal

1.6

121.2

3893

16273

R06AE07

ATC

cetirizine; oral

1.6

120.8

4637

20297

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

13.3

120.7

244

115

F31.8

ICD-10 Finland

Other bipolar affective disorders

14.6

120.6

235

101

S06.0

ICD-10 Finland

Concussion

2.2

120.2

1499

4514

UKC02

NOMESCO Finland

Cystoscopy

1.7

119.9

3420

13828

G44.2

ICD-10 Finland

Tension-type headache

2.4

118.8

1138

3011

E0000UV

ATC

1.6

117.3

4847

21564

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

116.4

5240

23784

N05AD01

ATC

haloperidol; systemic

3.5

115.7

615

1104

F90.0

ICD-10 Finland

Disturbance of activity and attention

4.8

115.3

444

588

N05AB01

ATC

dixyrazine; systemic

9.0

113.8

278

195

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

11.5

113.3

244

133

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.7

112.7

885

2090

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

112.5

4191

18138

G30.1

ICD-10 Finland

Alzheimer disease with late onset

2.4

112.2

1078

2856

EBA00

NOMESCO Finland

Extraction of tooth

1.6

112.1

4564

20184

F10.09

ICD-10 Finland

Alcohol intoxication UNS

5.1

112.0

407

505

N06BA04

ATC

methylphenidate; oral

5.7

111.8

369

408

KMAK

NOMESCO Finland

1.5

111.7

5601

25986

Z71.8

ICD-10 Finland

Other specified counselling

1.7

111.2

2729

10527

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

12.0

110.9

234

122

SPAT1246

SPAT

Screening of depression or other psychiatric problem

3.9

110.4

524

853

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

6.2

110.4

342

348

N06AA10

ATC

nortriptyline; systemic

11.7

110.0

235

126

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

108.7

2761

10752

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.0

108.2

1605

5191

N05CD02

ATC

nitrazepam; oral

5.3

107.9

379

452

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

107.3

6357

30499

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

107.1

2449

9230

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.2

106.3

1201

3448

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

14.6

106.2

207

C08CA01

ATC

amlodipine; oral

1.5

106.1

5290

24434

C10AA01

ATC

simvastatin; oral

1.5

105.4

7027

34498

N06AA22

ATC

51.7

105.3

149

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

104.6

9099

47078

H02AB06

ATC

prednisolone; systemic

1.5

104.1

6195

29689

A03CA02

ATC

clidinium and psycholeptics; oral

2.7

103.7

806

1889

P16

ICPC

Acute alcohol abuse

6.9

103.4

295

267

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

103.0

1673

5597

N06DA03

ATC

rivastigmine; oral, transdermal

2.9

102.6

716

1567

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

102.6

7821

39358

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

102.5

3114

12732

R35

ICD-10 Finland

Polyuria

2.2

102.3

1228

3623

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

102.3

1955

6937

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.4

102.2

968

2541

H03AA01

ATC

levothyroxine sodium; systemic

1.9

101.7

1796

6197

R52.2

ICD-10 Finland

Other chronic pain

4.4

101.5

419

597

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.0

101.4

1455

4635

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

9.5

100.7

238

157

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

100.7

2713

10720

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

5.4

100.3

346

404

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

100.3

2079

7579

L17

ICPC

Foot/toe symptom/complaint

1.6

99.9

3274

13643

D07AC01

ATC

betamethasone; topical

1.5

99.5

4346

19422

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

14.8

99.3

192

K59.0

ICD-10 Finland

Constipation

2.5

99.0

897

2298

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

12.8

98.1

201

R02

ICPC

Shortness of breath/dyspnoea

1.9

98.1

1670

5682

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.6

98.0

3195

13286

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.2

97.8

1122

3240

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

97.6

6417

31246

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

97.5

1499

4905

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

56.6

97.4

136

R41.0

ICD-10 Finland

Disorientation, unspecified

3.1

97.4

619

1272

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

3.7

97.3

485

824

F60.9

ICD-10 Finland

Personality disorder, unspecified

19.4

97.1

171

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

96.0

2197

8258

J01DA01

ATC

[U] cefalexin; systemic

1.4

95.8

8176

41813

G04BD08

ATC

solifenacin; oral

2.4

95.6

973

2649

F39

ICD-10 Finland

Unspecified mood [affective] disorder

8.6

95.6

239

175

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

22.0

95.5

162

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

2.5

95.4

865

2216

N06AC02

ATC

30.0

95.1

149

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

95.0

2268

8631

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.1

94.5

601

1235

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

94.4

1664

5727

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.1

94.3

1187

3573

SPAT1260

SPAT

Consultation of another employee

1.7

94.2

2413

9375

W19

ICD-10 Finland

Unspecified fall

2.0

94.1

1402

4529

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

7.5

93.9

254

212

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.0

92.7

624

1332

R33

ICD-10 Finland

Retention of urine

1.8

92.7

1921

6989

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

92.7

1866

6722

F31

ICD-10 Finland

Bipolar affective disorder

18.2

92.4

166

S01.0

ICD-10 Finland

Open wound of scalp

2.1

92.3

1269

3967

N03AF01

ATC

carbamazepine; oral, rectal

2.7

92.2

729

1726

N05CD08

ATC

midazolam; nasal, systemic

4.3

91.9

390

571

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.4

91.9

6330

30982

T90

ICPC

Diabetes non-insulin dependent

1.6

91.7

3472

14949

F43.1

ICD-10 Finland

Post-traumatic stress disorder

8.2

91.5

234

178

SPAT1262

SPAT

Handing over of treatment supplies

1.6

91.5

2826

11560

SPAT1310

SPAT

Counselling related to known health issue

1.5

91.4

4395

19987

N39.4

ICD-10 Finland

Other specified urinary incontinence

3.0

91.2

592

1234

M01AH01

ATC

celecoxib; oral (coxibs)

1.8

90.9

1869

6779

M01AX17

ATC

nimesulide; oral

1.6

90.4

2809

11502

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

90.4

2229

8556

J02AC01

ATC

fluconazole; systemic

1.7

89.8

2327

9058

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

7.5

89.5

243

204

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

6.1

89.2

277

283

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.4

89.0

841

2201

F03

ICD-10 Finland

Unspecified dementia

2.4

88.7

844

2217

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

88.3

1686

5960

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

87.9

2007

7517

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

87.3

2324

9112

M02AA07

ATC

piroxicam; topical

1.5

86.6

4090

18482

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.5

86.4

753

1884

R07.3

ICD-10 Finland

Other chest pain

2.0

85.7

1206

3800

N05AH02

ATC

clozapine; systemic

7.5

85.7

232

194

M25.5

ICD-10 Finland

Pain in joint

1.6

85.5

2648

10815

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.4

85.2

817

2155

R01AD08

ATC

fluticasone; nasal

1.6

84.7

2808

11670

N04AA02

ATC

biperiden; systemic

5.9

84.2

270

288

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.5

83.0

4299

19773

R52.9

ICD-10 Finland

Pain, unspecified

2.2

82.5

982

2878

N17

ICPC

Vertigo/dizziness

1.9

82.4

1352

4521

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.7

82.1

652

1546

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

2.6

82.0

697

1720

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

81.9

3519

15539

WX290

NOMESCO Finland

Other blockade of nerve

1.4

81.7

4844

22878

J01FF01

ATC

clindamycin; systemic

1.5

81.4

3299

14372

F05.9

ICD-10 Finland

Delirium, unspecified

3.6

81.0

417

728

F60.5

ICD-10 Finland

Anankastic personality disorder

23.9

80.9

134

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.2

80.9

935

2701

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

4.3

80.3

339

494

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

13.8

80.1

159

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

80.1

1568

5580

R5140

NOMESCO Finland

Monitoring the use of the aid

1.9

80.0

1424

4901

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

62.3

80.0

110

J01MA12

ATC

levofloxacin; systemic

1.6

79.9

2822

11891

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

6.6

79.8

234

221

F41.00

ICD-10 Finland

Moderate panic disorder

14.8

79.8

154

F41.3

ICD-10 Finland

Other mixed anxiety disorders

11.5

79.7

171

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

79.6

2606

10774

U04

ICPC

Incontinence urine

2.8

79.3

592

1351

R11

ICD-10 Finland

Nausea and vomiting

2.2

78.9

934

2727

R03BB04

ATC

tiotropium bromide; inhalant

1.7

78.1

1815

6819

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

11.2

78.0

169

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

6.0

77.8

244

253

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

77.6

3092

13395

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

76.9

2046

7996

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.9

76.8

1259

4203

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.6

76.8

2836

12066

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

76.6

2778

11768

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

76.6

1286

4333

M54

ICD-10 Finland

Dorsalgia

2.0

76.5

1084

3420

R55

ICD-10 Finland

Syncope and collapse

1.7

76.4

1707

6334

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

6.0

76.1

241

253

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

2.6

76.0

633

1542

A03FA02

ATC

cisapride; oral, rectal

2.1

76.0

1002

3068

F93.89

ICD-10 Finland

Other childhood emotional disorders

8.7

75.5

186

133

V03AB30

ATC

9.5

75.0

177

117

M01AH02

ATC

rofecoxib; oral

1.8

74.9

1501

5377

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

74.8

3712

16854

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

74.2

3252

14371

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

20.9

73.9

127

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.6

73.8

2168

8696

R13

ICD-10 Finland

Dysphagia

2.2

73.6

897

2652

J01FA06

ATC

roxithromycin; oral

1.4

73.5

4357

20484

F33.8

ICD-10 Finland

Other recurrent depressive disorders

57.8

73.5

102

K30

ICD-10 Finland

Functional dyspepsia

2.1

73.3

986

3043

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

73.0

1388

4882

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

5.9

73.0

234

250

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.4

72.5

690

1810

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

71.8

5853

29120

SPAT1252

SPAT

Overall medication plan or its review

2.0

71.6

1067

3432

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

14.6

71.2

138

IGV01

NOMESCO Finland

Psychiatric network contact

15.2

71.2

136

I95.1

ICD-10 Finland

Orthostatic hypotension

2.5

71.1

648

1661

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

70.7

1850

7183

SPAT1312

SPAT

General health counselling

1.4

70.1

4312

20372

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

70.0

2232

9136

P19

ICPC

Drug abuse

7.3

69.8

191

163

N05CD05

ATC

triazolam; oral, sublingual

4.7

69.7

272

366

N30.0

ICD-10 Finland

Acute cystitis

1.9

69.7

1137

3785

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

69.5

4175

19634

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

27.4

69.0

110

M02AA10

ATC

ketoprofen; topical

1.7

68.7

1640

6194

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

68.7

4003

18704

J01EA01

ATC

trimethoprim; systemic

1.6

68.7

2096

8478

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

5.5

68.2

230

262

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

68.2

3141

13995

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

6.5

67.9

202

195

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

17.8

66.6

120

D11

ICPC

Diarrhoea

1.9

66.5

1051

3455

WX002

NOMESCO Finland

Sedation and analgesia

1.5

66.5

2453

10392

A10BA02

ATC

metformin; oral

1.4

66.5

4175

19764

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.5

66.5

2505

10666

G04BD07

ATC

tolterodine; oral

2.5

66.4

610

1569

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

66.3

4551

21891

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

65.9

4534

21812

R41.3

ICD-10 Finland

Other amnesia

2.9

65.9

455

988

A29

ICPC

General symptom/complaint other

1.7

65.8

1457

5378

SPAT1167

SPAT

Insertion of urinary catheter

2.3

65.4

682

1874

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

65.3

2376

10029

P18

ICPC

Medication abuse

18.9

65.0

115

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

64.8

3747

17445

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

64.6

3459

15866

F60.6

ICD-10 Finland

Anxious [avoidant] personality disorder

51.5

64.5

R06.5

ICD-10 Finland

Mouth breathing

1.9

64.4

1085

3651

C10AA05

ATC

atorvastatin; oral

1.4

64.4

5507

27471

C05AA08

ATC

fluocortolone; rectal, topical

1.7

64.4

1553

5879

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.7

64.3

515

1227

SPAT1265

SPAT

Breathalyser

7.2

64.2

177

153

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.1

63.9

823

2492

E000001

ATC

1.5

63.7

2461

10526

Z72.1

ICD-10 Finland

Alcohol use

5.2

63.7

226

274

F20.9

ICD-10 Finland

Schizophrenia, unspecified

4.9

63.7

235

298

N05BA05

ATC

potassium clorazepate; oral

8.8

63.6

156

111

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

63.5

1863

7447

K59.1

ICD-10 Finland

Functional diarrhoea

2.4

63.4

586

1514

WZA90

NOMESCO Finland

Other doctors statement

1.5

63.4

2683

11713

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

27.3

63.3

101

D12

ICPC

Constipation

2.6

63.3

509

1214

G47.9

ICD-10 Finland

Sleep disorder, unspecified

3.8

63.3

304

501

A02BA04

ATC

nizatidine; systemic

1.9

62.9

1039

3472

X78

ICD-10 Finland

Intentional self-harm by sharp object

13.3

62.8

126

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

86.1

62.8

R05FB02

ATC

cough suppressants and expectorants

1.4

62.6

4310

20697

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

13.4

62.6

125

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

3.8

62.3

298

489

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

62.0

1841

7380

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

15.5

61.9

117

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.5

61.8

2727

12003

S22.3

ICD-10 Finland

Fracture of rib

1.9

61.8

980

3223

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

61.5

2173

9095

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.9

61.3

426

929

L01

ICPC

Neck symptom/complaint

1.8

61.2

1280

4635

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

2.2

60.9

674

1904

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.7

60.8

1562

6015

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

29.6

60.7

R4110

NOMESCO Finland

Physiotherapy

1.4

60.6

3146

14316

F22.0

ICD-10 Finland

Delusional disorder

6.0

60.5

190

198

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.5

60.3

541

1373

SPAT1238

SPAT

Brief therapy

7.9

60.3

157

124

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

60.2

3803

17958

J01FA10

ATC

azithromycin; systemic

1.3

59.9

6137

31400

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

59.8

731

2162

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3014576) Chloride [Moles/volume] in Serum or Plasma

9037

30561

1.62

320.02

7.4

7.1

104.0

104.6

mmol/l

22.06

8826

29926

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2729

6120

2.38

317.84

1.4

276.6

271.3

ug/g

0.50

1531

3580

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

8874

30026

1.62

312.96

8.1

6.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

7575

24606

1.68

312.45

4.0

3.1

—

(3027945) Reticulocytes/100 erythrocytes in Blood

8130

26955

1.65

310.26

2.4

2.6

1.8

1.7

5.67

7091

24026

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

8558

26286

1.80

307.65

1.9

1.7

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

64136

299164

2.70

307.65

19.6

14.2

76.7

77.5

umol/l

7.29

64113

298986

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

30419

101733

2.00

307.65

2.4

2.2

3053.8

76.5

nmol/l

0.50

27528

92236

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

64412

300730

2.79

307.65

12.2

9.2

27.7

26.5

u/l

21.49

62390

290430

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

1000

703

7.52

307.65

17.8

21.2

2334.9

2365.0

nmol/l

0.01

957

673

(3021589) Normoblasts [#/volume] in Blood

30235

118355

1.59

307.65

10.7

9.0

0.0

e9/l

0.80

24856

97702

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

7480

22339

1.84

307.65

2.8

2.4

44.3

46.7

u/l

0.12

6367

19248

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

60131

248470

3.06

307.65

5.6

4.2

1.9

2.1

mu/l

1.98

55919

228555

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

1032

921

5.92

307.65

3.1

2.5

31.8

25.6

ug/l

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

8496

26176

1.79

307.65

1.9

1.7

—

(3023183) Ammonium ion [Moles/volume] in Plasma

2208

4303

2.73

307.65

2.8

2.7

33.7

33.9

umol/l

0.13

1881

3625

(3019309) Folate [Moles/volume] in Red Blood Cells

16293

39502

2.51

307.65

1.9

1.7

1175.2

1151.7

nmol/l

2.17

12582

29905

(3042517) Benzodiazepines panel - Urine

385

31.55

307.65

3.2

1.8

—

(3013512) EKG study

18819

70963

1.53

307.65

4.1

3.7

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

20004

60535

2.02

307.65

2.4

2.2

2.9

mg/l

1.82

17080

51969

(44816559) Phosphatidylethanol [Mass/volume] in Blood

2647

3664

3.88

307.65

1.5

1.3

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

63622

280886

3.36

307.65

19.7

13.9

139.5

139.7

mmol/l

56.76

62190

273285

(3018095) Leukocytes [#/volume] in Urine

24766

91317

1.65

307.65

4.0

3.5

91.0

96.5

e6/l

0.35

17947

63636

(3022948) Iron [Moles/volume] in Serum or Plasma

12179

38939

1.77

307.65

2.4

2.6

13.2

13.8

umol/l

0.59

11137

36320

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

36024

120393

2.18

307.65

6.6

6.7

1.2

mmol/l

0.04

30087

101840

(3009261) Glucose [Presence] in Urine by Test strip

33356

134376

1.57

307.65

4.1

3.3

0.0

estimate

0.40

6872

24006

(3016879) Cocaine [Presence] in Urine

5453

9576

3.14

307.65

3.1

1.5

—

(3018418) pH of Serum or Plasma

22314

69949

1.98

307.65

3.9

4.3

7.4

1.32

4521

13188

(40761511) CBC panel - Blood by Automated count

63132

296932

2.30

307.65

16.6

11.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

15146

50004

1.74

307.65

1.5

1.4

2.4

g/l

0.20

9054

31754

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

6173

16858

2.00

307.65

1.7

1.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

46706

184748

1.99

307.65

4.0

2.7

53.0

44.9

u/l

49.19

43612

174025

(3027008) Opiates [Presence] in Urine

5615

10716

2.89

307.65

3.0

1.5

—

(3012544) pH of Venous blood

7254

22884

1.73

307.65

4.0

7.4

0.38

112

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

56257

246815

2.03

307.65

6.2

5.1

39.5

39.3

mmol/mol

4.69

52088

229975

(3026008) Bacteria identified in Urine by Culture

21278

73515

1.74

307.65

3.5

2.8

—

(3028707) Methadone [Presence] in Urine by Screen method

3879

2303

9.25

307.65

3.4

2.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

63716

281828

3.37

307.65

19.8

14.1

4.0

mmol/l

11.30

62187

273620

(3003458) Phosphate [Moles/volume] in Serum or Plasma

10142

31020

1.83

307.65

5.2

6.4

1.0

mmol/l

2.84

9402

29049

(3027944) Amphetamines [Presence] in Urine

5433

10655

2.80

307.65

2.9

1.5

—

(3015736) pH of Urine

27162

101231

1.66

307.65

3.7

3.1

5.7

—

(3019150) Specific gravity of Urine by Refractometry

15908

56807

1.60

307.65

4.4

3.6

1.0

kg/l

0.51

2037

9040

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

55927

264577

1.54

307.65

4.1

3.6

1.4

1.3

mmol/l

290.38

51050

245836

(3000963) Hemoglobin [Mass/volume] in Blood

65859

321829

2.52

307.65

26.6

17.7

135.1

136.4

g/l

82.79

65016

317376

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

26430

93670

1.77

307.65

4.1

3.2

64.5

63.3

ng/l

0.04

17392

60944

(3029937) Albumin [Presence] in Urine by Test strip

18971

70648

1.55

307.65

4.6

3.6

0.0

estimate

1.02

6859

23594

(42870588) Differential panel, method unspecified - Blood

24999

87612

1.77

307.65

5.9

6.0

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

62229

281760

2.57

307.65

17.8

12.3

22.3

23.9

mg/l

23.78

51593

218553

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

16131

56272

1.65

307.65

1.8

1.7

1.1

1.2

mg/l

4.72

11998

42810

(3011397) Hemoglobin [Presence] in Urine by Test strip

16041

60799

1.49

307.65

4.0

3.3

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

37480

130885

2.08

307.65

6.1

6.0

10.5

11.7

umol/l

53.88

35208

124276

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

11895

41042

1.62

307.65

1.3

1.2

8.0

12.7

u/ml

11.06

4410

16455

(3001604) Monocytes [#/volume] in Blood

35602

130948

1.87

307.65

6.2

5.7

0.6

e9/l

1.32

31037

113891

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

14464

28572

3.08

307.65

2.2

1.5

1.4

109.56

12663

25672

(3007853) Bacteria identified in Skin by Aerobe culture

9525

29811

1.77

307.65

1.9

1.7

—

(3019198) Lymphocytes [#/volume] in Blood

36557

135644

1.86

307.65

6.2

5.7

2.0

1.9

e9/l

1.94

32390

120093

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

1257

444

15.02

307.65

11.1

14.2

0.6

mmol/l

3.16

1149

414

(3021447) Carbon dioxide [Partial pressure] in Venous blood

7065

22050

1.75

307.65

4.0

3.9

5.9

5.8

kpa

9.49

6802

21445

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

59371

263563

2.26

307.65

4.9

4.0

6.0

5.9

mmol/l

54.53

54387

242593

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

57735

274213

1.61

307.65

4.5

4.0

1.4

1.5

mmol/l

213.88

53075

255860

(40758558) Short blood count panel - Blood

18020

64325

1.62

307.65

7.1

6.7

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

53615

202888

2.70

307.65

4.6

3.6

14.6

14.8

pmol/l

88.03

49178

184787

(3002030) Lymphocytes/100 leukocytes in Blood

33942

128827

1.74

307.65

6.4

5.9

28.1

0.26

31628

120564

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

8436

27357

1.69

307.65

7.4

5.1

5.0

kpa

9.03

8044

26065

(40760892) CBC W Ordered Manual Differential panel - Blood

16366

60171

1.55

307.65

4.7

4.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

13387

47530

1.58

307.65

4.1

3.5

282.8

597.9

ng/l

12.29

9707

35910

(3032080) INR in Blood by Coagulation assay

27495

101325

1.69

307.65

8.9

8.6

1.2

1.3

inr

12.81

8726

29250

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

14101

41101

1.99

307.65

2.8

3.1

2.4

mmol/l

9.81

12243

35938

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

17592

57158

1.81

307.65

1.3

1.4

1.9

u/ml

5.66

4650

15973

(3035941) MCH [Entitic mass]

65846

321610

2.52

307.65

26.3

17.5

30.3

30.2

24.83

65005

317153

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

4964

13664

1.96

307.65

3.4

3.5

1.7

1.6

mmol/l

0.60

3723

9830

(3021601) Nitrite [Presence] in Urine by Test strip

33047

132913

1.57

307.65

5.3

4.5

0.0

estimate

1.30

7096

24722

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

6360

19190

1.80

307.65

3.9

1.2

mmol/l

1.05

5460

16944

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

12053

43042

1.56

307.65

2.9

2.7

1.4

1.1

e6/l

0.56

6825

24461

(3024731) MCV [Entitic volume]

65851

321651

2.53

307.65

26.3

17.6

91.0

90.6

75.10

65008

317178

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

7357

21999

1.83

307.65

2.3

0.2

g/l

5.60

6691

20610

(3020191) Ethanol [Moles/volume] in Serum or Plasma

1291

1535

4.45

307.65

1.7

1.3

1.5

1.3

promille

2.95

960

1228

(3011288) Drugs identified in Urine by Screen method

4826

5631

4.73

307.65

4.1

2.1

—

(3009508) Creatinine [Moles/volume] in Urine

22005

78046

1.69

307.65

3.4

3.2

7.8

8.1

mmol/l

0.63

18489

66289

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1130

668

8.95

307.65

1.9

2.1

—

(36304419) Bacteria [Presence] in Urine

19454

68287

1.68

307.65

3.4

2.9

—

(3006315) Basophils [#/volume] in Blood

35776

131549

1.87

307.65

6.2

5.7

0.0

e9/l

2.80

31168

114424

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

33050

108295

2.14

307.65

6.0

1.2

mmol/l

0.85

30049

98173

(3048689) Calprotectin [Mass/mass] in Stool

10374

31414

1.85

307.65

2.3

2.5

127.9

140.2

ug/g

2.00

7972

25074

(3018010) Neutrophils/100 leukocytes in Blood

33460

126872

1.73

307.65

6.2

5.7

57.2

0.03

31270

119262

(3031040) Bacteria [#/volume] in Urine by Automated count

44566

175468

1.92

307.65

5.3

3.9

1799.1

1107.4

e6/l

1.27

657

2419

(3028300) Cannabinoids [Presence] in Urine

5640

10733

2.90

307.65

3.1

1.5

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

8784

20080

2.47

307.65

2.1

2.3

366.9

380.3

nmol/l

6.48

7991

18638

(3023368) Bacteria identified in Blood by Culture

20002

66500

1.80

307.65

4.8

4.1

—

(3009343) pH of Capillary blood

5115

14178

1.95

307.65

3.5

7.4

2.16

781

1818

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

24666

77934

2.01

307.65

2.9

2.5

55.9

59.6

u/l

10.55

22553

72374

(40768797) Stomach Pathology biopsy report

10569

32584

1.82

307.65

1.3

1.2

—

(3019069) Monocytes/100 leukocytes in Blood

33178

124466

1.75

307.65

6.6

6.2

8.5

8.6

11.88

31049

117042

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

57751

260358

1.97

307.65

15.5

11.6

85.3

83.5

ml/min/173m2

63.89

48315

212664

(3037467) Urinalysis macro (dipstick) panel - Urine

45804

186288

1.84

307.65

4.8

3.9

—

(3003396) Base excess in Arterial blood by calculation

8438

27354

1.69

307.65

7.4

7.3

1.2

0.9

mmol/l

7.54

6656

21261

(3026782) Osmolality of Urine

14714

48735

1.73

307.65

2.9

2.7

530.3

560.4

mosm/kgh2o

43.09

12598

41602

(3007461) Platelets [#/volume] in Blood

65832

321283

2.54

307.65

26.5

17.6

255.8

250.4

e9/l

75.45

64480

312661

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

30870

96259

2.22

307.65

2.1

1.9

95.8

95.4

pmol/l

0.70

16906

51044

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

25646

103756

1.46

307.65

4.3

3.4

—

(3035350) Ketones [Presence] in Urine by Test strip

33131

132510

1.59

307.65

4.1

3.3

0.0

estimate

2.75

6914

24047

(3022096) Basophils/100 leukocytes in Blood

32043

119887

1.74

307.65

6.4

6.0

0.7

0.09

29855

112263

(3001122) Ferritin [Mass/volume] in Serum or Plasma

33074

115113

1.96

307.65

3.1

2.8

115.2

125.8

ug/l

7.76

30468

107667

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

10878

37723

1.60

307.65

2.4

2.0

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

5281

15114

1.89

307.65

2.9

3.6

4.4

4.6

pmol/l

9.06

4596

13687

(3027801) Oxygen [Partial pressure] in Arterial blood

8431

27343

1.69

307.65

7.4

7.3

11.9

12.8

kpa

41.01

8041

26048

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

59270

280436

1.73

307.65

5.0

4.4

2.7

2.8

mmol/l

50.27

54534

261011

(3013707) Erythrocyte sedimentation rate by Westergren method

49791

196123

2.17

307.65

4.4

3.8

11.7

11.5

mm/h

1.16

46120

182268

(3015377) Calcium [Moles/volume] in Serum or Plasma

25968

78586

2.16

307.65

3.1

3.4

2.3

2.4

mmol/l

2.50

22826

68851

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

23133

72063

2.02

307.65

2.4

2.0

236.1

205.3

u/l

2.11

21674

67769

(3013650) Neutrophils [#/volume] in Blood by Automated count

40190

152269

1.90

307.65

9.7

8.5

4.2

4.1

e9/l

17.74

35419

133128

(3010813) Leukocytes [#/volume] in Blood

65860

321770

2.52

307.65

26.5

17.6

6.9

6.7

e9/l

85.87

64334

312253

(3006504) Eosinophils/100 leukocytes in Blood

32987

123765

1.75

307.65

6.4

5.9

2.8

2.9

1.46

30696

115826

(3021960) Folate [Moles/volume] in Serum or Plasma

18686

51938

2.20

307.65

1.6

1.5

19.9

20.2

nmol/l

1.31

16367

44678

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

58214

276228

1.64

307.65

4.6

4.0

4.6

4.7

mmol/l

70.80

53816

258697

(3002032) Base excess in Venous blood by calculation

7057

21967

1.75

307.65

4.0

1.9

1.8

mmol/l

2.45

5731

17951

(3030467) Casts [#/volume] in Urine by Automated count

19912

69935

1.68

307.65

3.4

3.0

0.4

e6/l

0.25

15274

52171

(3013115) Eosinophils [#/volume] in Blood

36743

136122

1.87

307.65

6.5

5.9

0.2

e9/l

2.02

32435

120045

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

25983

83291

2.01

307.65

3.6

3.1

33.3

33.8

u/l

0.29

24433

79323

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

52372

200479

2.51

307.65

8.0

7.2

77.6

77.3

u/l

0.48

49377

189000

(3000764) Benzodiazepines [Presence] in Urine

5626

10586

2.93

307.65

3.1

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

4933

7387

3.68

307.65

3.1

1.6

—

(3042936) Bacteria identified in Isolate by Culture

10476

35827

1.62

307.65

2.2

2.0

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

16846

48662

2.07

307.65

1.7

1.6

28315846.9

39666398.7

pmol/l

1.50

13950

40715

(3013826) Glucose [Moles/volume] in Serum or Plasma

40193

152220

1.91

307.65

5.4

4.5

6.7

mmol/l

1.59

37756

140542

(3004789) Transferrin [Mass/volume] in Serum or Plasma

11226

35771

1.76

307.65

2.4

2.6

2.4

2.3

g/l

17.25

10193

33339

(3009466) Valproate [Moles/volume] in Serum or Plasma

2151

1984

5.81

307.65

5.2

4.5

361.4

367.0

umol/l

0.67

1863

1692

(3002582) Erythrocytes [#/volume] in Urine

21525

77014

1.67

307.65

3.5

3.1

69.8

97.7

e6/l

2.04

16790

58715

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

10073

33880

1.65

307.65

2.3

2.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

12336

38754

1.80

307.65

2.0

1.8

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

5165

14372

1.95

307.65

3.5

5.2

5.1

kpa

10.25

4771

13255

(4198724)

1043

624

8.84

307.65

2.6

2.2

—

(3002385) Erythrocyte distribution width [Ratio]

51507

237492

1.52

307.65

20.9

14.8

13.7

13.6

26.15

50479

232456

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

955

660

7.64

307.65

13.2

14.3

813.4

1597.3

nmol/l

0.47

920

636

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

8823

28156

1.73

307.65

2.7

2.8

7.6

9.0

umol/l

6.69

7360

24786

(3017446) Testosterone [Moles/volume] in Serum or Plasma

6931

20330

1.87

307.65

2.5

2.0

12.6

12.4

nmol/l

0.81

6038

18309

(3033658) Prothrombin time (PT) actual/Normal

17916

64904

1.59

307.65

4.4

3.8

91.4

89.8

14.21

17331

63345

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

805

586

7.24

307.65

2.4

1.6

146.0

113.9

umol/l

1.18

426

282

(3012095) Magnesium [Moles/volume] in Serum or Plasma

12575

38531

1.86

307.65

3.4

3.5

0.8

mmol/l

7.03

11646

36082

(3037522) Nuclear Ab [Titer] in Serum

10612

34936

1.69

307.65

1.4

1.3

458.5

566.5

titre

7.39

1972

7168

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

12618

43702

1.62

307.65

1.3

26.5

36.9

iu/ml

7.29

3542

14108

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

10378

33347

1.73

307.65

2.5

2.7

22.4

23.2

4.98

8749

28619

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

18231

67333

1.56

307.65

3.1

3.0

1242.2

1493.3

ng/l

11.66

15142

57760

(3014111) Lactate [Moles/volume] in Serum or Plasma

6860

20913

1.79

307.65

6.7

7.2

1.4

1.3

mmol/l

3.77

6573

20180

(3024561) Albumin [Mass/volume] in Serum or Plasma

31860

106037

2.06

307.65

4.8

4.9

35.8

35.6

g/l

6.80

29429

98627

(3044889) 12 lead EKG panel

44718

182123

1.80

307.65

4.0

3.4

—

(3026361) Erythrocytes [#/volume] in Blood

65854

321687

2.53

307.65

26.4

17.6

4.5

e12/l

106.82

64312

312191

(3000850) Epithelial cells [#/volume] in Urine

15750

52483

1.73

307.65

2.8

2.5

6.0

5.3

e6/l

8.22

13877

45783

(3020682) Albumin/Creatinine [Ratio] in Urine

19193

76766

1.42

306.53

4.0

8.8

9.8

mg/mmol

1.64

12124

49651

(3012516) Albumin [Mass/volume] in Urine

18300

72746

1.43

301.22

3.3

442.7

409.7

mg/l

0.37

11673

46828

(3017143) Hepatitis C virus Ab [Presence] in Serum

9669

33745

1.58

298.91

1.7

1.6

—

(3016502) Oxygen saturation in Arterial blood

7490

24566

1.66

296.90

7.8

7.7

95.4

95.9

6.16

7246

23580

(3021387) Prolactin [Units/volume] in Serum or Plasma

3688

9678

2.04

295.32

1.7

1.6

338.6

290.9

mu/l

6.29

3281

8835

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

583

404

7.58

294.98

2.3

2.6

135.0

156.3

nmol/l

2.45

498

353

(3018677) aPTT in Platelet poor plasma by Coagulation assay

10738

38501

1.54

294.58

2.1

2.2

29.8

0.19

10370

37395

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

11168

40398

1.53

294.32

3.1

2.8

3.0

2.7

e6/l

2.08

5971

21967

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

2389

5222

2.44

293.32

2.1

1.8

195.0

197.0

pmol/l

0.38

2256

4978

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

4871

14176

1.85

290.15

1.6

1.5

—

(3044640) Blood type and Crossmatch panel - Blood

20689

84496

1.40

289.53

2.5

2.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

5808

17895

1.76

287.50

3.4

3.2

4.7

4.6

kpa

1.14

5552

17337

(36660697) Celiac disease serology panel - Serum

6372

20259

1.71

282.37

1.2

—

(3019060) Gas panel - Arterial blood

5154

15432

1.80

280.19

5.2

4.8

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

2478

5664

2.33

276.31

1.3

501.2

550.0

mg/l

1.80

2347

5415

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

29745

129778

1.34

269.58

4.3

3.9

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

3093

7919

2.09

263.34

2.0

1.6

38.5

41.8

nmol/l

10.55

3003

7751

(3019225) pH of Specimen

7035

23384

1.63

262.66

4.1

4.2

—

(3025941) Bacteria identified in Stool by Culture

4884

14751

1.78

257.14

1.3

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

55382

266786

1.42

256.40

18.7

12.8

39.8

40.1

12.77

38822

202220

(3026493) Urate [Moles/volume] in Serum or Plasma

17213

69262

1.40

255.78

2.6

3331.0

4540.3

umol/l

3.92

14759

60961

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

3067

7918

2.07

255.43

2.3

2.4

481.3

596.4

ug/l

0.97

2855

7413

(3000991) Gas panel - Venous blood

6224

20188

1.67

254.79

8.1

8.6

—

(40761536) Microorganisms panel - Urine sediment

6703

22228

1.63

251.91

4.4

3.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

16654

66791

1.40

251.50

1.7

1.6

1.5

1.3

mmol/l

85.41

13832

56824

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

2194

4972

2.34

248.94

1.4

2766.9

1721.7

e6/l

0.26

1790

4019

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

2192

4968

2.34

248.65

1.3

1.4

19.0

36.7

e6/l

1.55

1684

3827

(3000494) Fungus identified in Specimen by Culture

8389

29452

1.55

248.61

1.5

1.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

6791

22808

1.61

242.03

8.3

8.1

122.7

121.7

g/l

3.26

6584

21943

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

2182

5001

2.32

241.42

1.2

1.3

3.8

3.7

mmol/l

2.05

2051

4695

(3022217) INR in Platelet poor plasma by Coagulation assay

8904

31961

1.52

237.86

22.3

24.2

1.3

1.4

inr

4.18

1242

4650

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

6138

20234

1.64

235.11

2.5

2.2

6.8

7.8

ug/l

2.22

5185

17845

(3022145) Colonoscopy Study observation

8051

28345

1.55

234.52

1.3

1.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3832

11078

1.85

231.19

4.0

4.5

24.2

24.0

mmol/l

2.80

3391

9984

(3010421) pH of Blood

2465

6073

2.16

230.47

4.3

3.7

7.4

4.32

2125

5185

(3022313) Gas panel - Capillary blood

3585

10150

1.89

230.41

3.6

3.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

14822

59022

1.39

229.59

2.1

1.9

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

41915

194598

1.32

228.90

3.4

3.0

—

(3005719) IgG [Mass/volume] in Serum or Plasma

5810

19012

1.65

228.65

2.4

2.8

10.4

10.7

g/l

5.80

5206

17516

(4010399)

5397

17382

1.67

225.43

1.5

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

4459

13623

1.76

224.72

1.8

1.6

—

(40761535) Cells panel - Urine sediment

6049

20116

1.62

223.21

3.8

3.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

17970

74148

1.36

222.55

3.6

3.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

2992

8081

1.97

220.06

1.4

8.8

9.6

u/l

2.59

2371

6711

(1002224) Polysomnography panel

3565

10225

1.86

220.06

1.1

1.0

—

(3023520) Reticulocytes [#/volume] in Blood

5988

19930

1.62

220.04

2.4

2.7

71.6

68.6

e9/l

6.65

4473

15107

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

4656

14503

1.72

219.25

6.6

7.3

24.9

24.6

mmol/l

6.17

4598

14387

(3020779) Urea [Moles/volume] in Serum or Plasma

6443

21959

1.59

214.58

6.8

8.0

9.0

10.1

mmol/l

25.58

6086

20898

(3013290) Carbon dioxide [Partial pressure] in Blood

2183

5294

2.19

211.79

4.4

3.7

5.1

5.0

kpa

8.51

2126

5179

(3027315) Oxygen [Partial pressure] in Blood

2192

5327

2.18

211.59

4.4

3.7

8.7

kpa

0.16

2134

5212

(3012501) Base excess in Blood by calculation

2182

5293

2.19

211.55

4.4

3.7

2.5

2.4

mmol/l

0.44

1514

3501

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

3145

8768

1.91

211.11

3.7

3.8

24.8

24.7

mmol/l

1.32

2900

8094

(1616796) Gas panel - Central venous blood

2154

5222

2.19

209.10

3.8

3.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

4728

14990

1.69

208.56

7.9

6.9

24.8

24.4

mmol/l

7.10

4458

13917

(3020630) Protein [Mass/volume] in Serum or Plasma

5799

19407

1.61

207.81

2.3

2.6

66.6

g/l

0.36

5238

17773

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

15691

63979

1.36

206.59

2.5

2.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

3341

9589

1.86

205.44

1.2

0.7

0.9

u/ml

0.57

282

814

(3003181) Sodium [Moles/volume] in Urine

1600

3433

2.47

203.38

1.5

1.3

61.4

64.7

mmol/l

1.99

1228

2773

(3004588) Protein electrophoresis panel - Serum or Plasma

4836

15570

1.67

201.22

2.1

2.4

—

(3020891) Body temperature

3209

9160

1.87

200.53

5.4

4.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

5406

17969

1.62

198.66

1.2

113.1

151.9

iu/ml

9.73

1897

6967

(3044290) Cell count panel - Cerebral spinal fluid

1976

4767

2.20

193.92

1.3

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2600

6982

1.98

193.85

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

2615

7055

1.97

192.44

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

2616

7076

1.97

191.11

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

5205

17317

1.61

190.16

2.4

2.3

23.1

23.2

au/ml

0.02

256

1119

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

5089

16877

1.62

188.24

2.1

1.8

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

4821

15777

1.64

187.92

1.3

46.2

50.3

au/ml

0.45

161

676

(3028026) IgM [Mass/volume] in Serum or Plasma

4540

14733

1.65

182.61

1.8

1.9

1.3

g/l

0.81

4106

13511

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

6119

21394

1.54

180.60

2.3

1.9

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4262

13691

1.67

178.01

1.1

1.0

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

3584

10985

1.74

177.29

3.3

2.8

1.5

1.2

22.90

3571

10928

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2371

6376

1.97

175.83

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

3917

12348

1.69

175.33

1.4

1.3

24.4

27.4

iu/l

6.13

3280

10739

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

7859

29168

1.46

173.65

3.5

4.5

234.3

244.9

u/l

6.84

7332

27726

(40768804) Tissue Pathology biopsy report

24749

109647

1.28

172.37

2.1

2.0

—

(3017181) Myelocytes/100 leukocytes in Blood

6144

21735

1.52

171.39

4.0

4.2

0.9

0.19

1689

6055

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1374

2996

2.42

168.77

1.6

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

4547

15057

1.62

168.41

9.1

9.3

1.5

1.3

20.15

4515

14947

(3002179) Metamyelocytes/100 leukocytes in Blood

5651

19708

1.54

168.01

3.8

4.0

0.6

0.7

1.43

1219

4389

(3014007) Fractional oxyhemoglobin in Arterial blood

4550

15098

1.61

167.08

9.2

9.4

93.5

94.1

8.47

4533

15045

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

3485

10783

1.72

166.52

3.2

2.8

0.7

0.49

3347

10377

(3003327) Ova and parasites identified in Stool by Light microscopy

2930

8617

1.81

166.09

1.7

—

(3018405) Lactate [Moles/volume] in Arterial blood

2796

8104

1.83

166.01

4.6

4.1

1.4

mmol/l

0.51

2753

7949

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

4532

15050

1.61

165.85

9.2

9.4

0.7

0.67

4502

14954

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

13406

54881

1.34

165.78

1.7

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

2124

5608

2.01

165.52

1.5

1.3

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

5136

17591

1.57

165.19

3.4

4.2

86.8

94.3

ng/l

5.25

4400

15314

(3021440) Promyelocytes/100 leukocytes in Blood

5844

20722

1.51

160.68

4.1

4.2

0.1

0.29

1561

5650

(40767503) Oxygen content in Capillary blood by calculation

1929

4997

2.04

158.11

2.8

2.4

16.7

16.5

0.58

1006

2556

(3004119) Hemoglobin [Mass/volume] in Venous blood

4368

14613

1.60

154.69

3.7

3.3

130.1

129.3

g/l

1.37

4265

14297

(3013139) Helicobacter pylori Ag [Presence] in Stool

4860

16713

1.56

153.08

1.2

—

(3025159) Blasts/100 leukocytes in Blood

5518

19558

1.51

151.54

4.1

4.2

0.0

0.3

5.17

1319

4792

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

3230

10053

1.71

150.78

1.1

8.2

12.2

u/ml

0.26

146

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

5572

19933

1.50

146.19

3.0

2.9

186.3

216.3

ng/l

4.80

5011

18151

(3005322) IgE [Units/volume] in Serum or Plasma

4804

16653

1.54

145.77

1.3

291.0

248.6

u/ml

0.75

4411

15453

(3028271) Lactate [Moles/volume] in Capillary blood

1505

3653

2.17

145.25

2.1

1.8

1.7

mmol/l

0.02

1478

3554

(3015235) Bicarbonate [Moles/volume] in Capillary blood

2131

5907

1.91

144.57

3.1

2.9

24.7

24.4

mmol/l

2.86

1885

5180

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

3823

12589

1.62

144.02

9.1

9.7

24.3

24.2

mmol/l

1.05

3509

11805

(3020961) Endomysium IgA Ab [Titer] in Serum

3748

12365

1.61

140.03

1.1

217.6

210.8

titre

0.04

383

(3043409) Potassium [Moles/volume] in Arterial blood

2399

7005

1.81

138.73

4.8

4.4

3.8

3.9

mmol/l

4.33

2252

6591

(3008295) Osmolality of Serum or Plasma

966

1948

2.61

138.66

1.5

1.4

279.0

280.2

mosm/kgh2o

0.70

709

1559

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1838

4913

1.98

138.24

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1837

4910

1.98

138.19

1.4

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

751

1324

2.98

136.78

1.7

1.3

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1920

5242

1.94

136.03

2.9

8.3

kpa

0.04

1782

4863

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2540

7624

1.77

134.13

1.9

1.7

—

(3007566) Smooth muscle Ab [Titer] in Serum

2334

6879

1.80

130.87

1.2

1.3

86.0

129.9

titre

2.63

230

652

(3052851) Hemolysis interference index of Serum or Plasma

2422

7292

1.76

126.49

3.3

3.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

3637

12246

1.58

124.52

2.4

2.3

5132.6

6534.2

u/l

1.52

1079

5337

(3034770) Mitochondria Ab [Titer] in Serum

2272

6773

1.78

122.61

1.2

637.9

1087.2

titre

2.33

200

(3021901) Oxygen saturation in Capillary blood

1609

4281

1.98

122.48

2.8

2.7

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

594

969

3.22

122.35

1.8

1.4

1954014.6

1686166.2

iu/ml

0.16

(3027273) Bicarbonate [Moles/volume] in Venous blood

3483

11713

1.58

119.74

3.8

3.4

25.2

25.1

mmol/l

0.74

3374

11366

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

3688

12595

1.56

118.66

2.4

—

(3007463) Buprenorphine [Presence] in Urine

125

38.43

118.58

7.8

4.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

647

1150

2.95

116.31

1.0

749.6

733.1

ng/l

0.34

432

799

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

645

1145

2.96

116.20

1.0

285.7

370.7

ng/l

1.89

442

834

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

647

1152

2.95

115.98

1.0

40.6

43.3

ng/l

0.52

430

829

(3022806) Fractional oxyhemoglobin in Capillary blood

1222

2997

2.15

114.93

2.1

1.7

89.6

90.0

1.53

1207

2948

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2903

9522

1.62

110.37

2.1

2.0

2.4

ug/l

0.87

2514

8439

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1428

3782

1.99

110.04

1.4

1.3

23.0

25.7

u/l

2.14

1128

3201

(3021879) Hepatitis B virus core Ab [Presence] in Serum

5813

22087

1.41

109.65

1.5

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

3194

10766

1.57

108.48

4.2

3.9

51.1

47.6

11.75

3154

10660

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1914

5620

1.80

108.43

2.3

2.2

131.8

130.5

g/l

1.12

1437

4098

(3016650) Hepatitis A virus Ab [Presence] in Serum

1539

4218

1.92

107.68

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

3275

11273

1.54

101.35

1.6

1.8

1.6

1.5

g/l

2.58

2792

9652

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1793

5274

1.79

100.94

1.4

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

806

1764

2.40

98.24

1.6

2.2

19.2

18.9

nmol/l

0.30

742

1688

(3023410) Appearance of Cerebral spinal fluid

966

2296

2.21

97.97

1.4

1.5

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

1022

2488

2.16

97.88

1.1

52.0

62.9

au/ml

—

(3017732) Neutrophils [#/volume] in Blood

4862

18249

1.42

97.69

2.9

2.6

4.1

e9/l

0.14

3730

14366

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

1014

2467

2.16

97.26

1.3

29.1

32.5

nmol/l

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

1040

2559

2.14

97.04

1.1

78.1

16.1

au/ml

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2813

9443

1.58

96.99

1.6

1.7

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1486

4173

1.88

96.73

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

1029

2537

2.13

95.54

1.3

1.4

—

(21494755) Public health laboratory ask at order entry panel

4877

34424

0.72

95.44

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

1290

3468

1.96

95.34

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

918

2174

2.22

93.91

1.4

1.5

—

(3000492) Spirometry study

6631

26394

1.34

93.11

1.5

1.4

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

195

147

6.94

93.00

1.5

1.1

1.0

—

mmol/l

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

2286

7371

1.64

92.75

1.9

1.6

—

(3003338) MCHC [Mass/volume]

50502

249400

1.21

92.68

23.0

15.1

332.7

332.9

g/l

7.67

50075

247364

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1541

4444

1.83

92.40

1.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

3032

10490

1.53

91.50

2.1

1.9

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3720

13495

1.46

89.33

10.0

9.7

—

(3008898) HLA-B27 [Presence]

2716

9235

1.56

88.49

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2787

9537

1.55

88.29

2.0

1.8

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

3955

14555

1.44

88.10

1.3

1.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

222

210

5.53

87.53

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

19435

88487

1.20

87.12

4.7

2.8

3.4

ug/l

1.48

17150

80067

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

2360

7797

1.60

86.82

1.9

1.8

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2485

8316

1.58

86.67

2.1

2.3

3.0

3.1

g/l

0.98

1922

6451

(3016038) Potassium [Moles/volume] in Urine

622

1276

2.56

86.51

1.3

1.2

33.2

35.6

mmol/l

1.46

504

1128

(3009445) Proteinase 3 Ab [Units/volume] in Serum

3148

11144

1.50

85.23

1.4

1.6

11.2

14.0

u/ml

0.46

366

(3035637) Corticotropin [Mass/volume] in Plasma

1081

2840

2.00

85.16

1.5

1.6

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2613

8890

1.55

84.86

2.1

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2615

8901

1.55

84.75

2.1

2.3

7.4

g/l

0.01

1963

6581

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

2267

7463

1.60

84.60

2.2

2.5

0.8

0.9

g/l

1.10

1928

6414

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1418

4101

1.82

84.25

1.5

0.3

0.4

nmol/l

3.87

1091

3310

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2606

8880

1.55

84.05

2.1

2.3

3.8

3.9

g/l

1.03

1881

6284

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2457

8274

1.57

83.40

2.1

2.3

10.0

10.4

g/l

3.41

2036

6928

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2091

6781

1.63

82.86

2.1

2.2

38.0

37.6

g/l

1.75

1779

5839

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

908

2276

2.10

80.93

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

11417

49564

1.24

80.83

1.7

—

(3024928) Oxygen saturation in Venous blood

1619

4935

1.73

80.74

3.3

3.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

771

1809

2.24

80.65

1.2

2.0

2.1

mmol/l

0.74

720

1676

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

3047

10868

1.48

79.42

1.8

2.0

39.4

39.3

u/l

0.05

2709

9703

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

5302

20869

1.35

79.40

2.7

2.6

68.8

66.4

ml/min/173m2

3.56

2205

8069

(3047181) Lactate [Moles/volume] in Blood

2339

7913

1.56

77.77

6.3

5.6

1.3

mmol/l

1.97

2089

6975

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2352

7974

1.56

77.48

1.7

1.2

g/l

9.75

2241

7592

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2294

7738

1.57

77.24

1.7

0.2

g/l

4.01

2183

7331

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

2015

6603

1.61

76.55

2.1

2.3

0.0

g/l

0.03

1814

6061

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

811

1996

2.13

75.70

1.2

1.1

38.2

47.1

mg/l

4.08

666

1693

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

2093

6942

1.59

75.67

1.2

1.3

32.7

38.1

u/ml

0.38

111

433

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1878

6075

1.63

75.11

2.2

2.3

0.0

g/l

0.33

1682

5557

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

7463

31082

1.28

74.42

4.5

4.2

31.1

32.5

19.83

5295

21659

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

2520

8754

1.52

74.40

1.6

288.4

289.0

titre

0.00

100

366

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

785

1924

2.14

74.04

1.1

254.1

277.2

mg/l

1.27

680

1711

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1630

5114

1.68

73.26

1.2

39.5

45.8

u/ml

0.65

152

501

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1846

5996

1.62

72.64

2.2

2.3

0.0

g/l

0.00

1675

5545

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1801

5814

1.63

72.60

1.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

7536

31544

1.28

72.03

1.7

1.8

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1743

5595

1.64

71.83

1.6

1.7

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

2211

7535

1.55

71.14

1.1

3.1

6.5

u/ml

5.49

246

1036

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2800

10037

1.47

71.06

1.6

3.6

mg/l

0.04

2167

6575

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2599

9196

1.49

70.30

1.3

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

2544

19064

0.68

69.35

1.4

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

752

1862

2.12

69.19

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2839

10261

1.46

69.08

5.7

4.8

1.8

1.6

12.44

2679

9611

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1220

3619

1.77

66.76

1.6

1.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

2778

10087

1.46

65.97

5.7

4.9

0.9

1.17

2627

9443

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

4431

30135

0.75

65.84

1.7

—

(4027681)

640

1522

2.20

64.98

1.3

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2341

8248

1.50

64.57

2.7

2.6

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

565

1278

2.32

64.31

1.1

3.6

6.7

nmol/l

0.90

105

263

(3014271) Vancomycin [Susceptibility]

495

1058

2.45

63.57

3.2

2.8

—

(3040151) Glucose [Moles/volume] in Capillary blood

970

2728

1.87

62.92

14.2

5.8

7.3

7.4

mmol/l

0.07

802

2210

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1126

3323

1.78

62.70

1.3

0.2

0.3

nmol/l

1.61

191

(40768443) Skin Pathology biopsy report

3005

11249

1.41

60.44

1.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1121

3342

1.76

60.35

1.3

1.0

1.4

nmol/l

0.28

1074

3223

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1896

6490

1.54

59.76

1.3

8.0

9.6

u/ml

0.43

271

1024

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

775

2073

1.96

58.22

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1864

6408

1.53

57.62

1.3

6.5

7.6

u/ml

0.18

173

686

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1309

4141

1.66

57.05

1.6

1.7

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

1310

4151

1.66

56.74

1.5

1.6

0.7

0.8

g/l

3.50

966

3135

(3034860) Kappa light chains.free [Mass/volume] in Serum

2102

7443

1.49

56.54

3.0

3.4

52.1

66.5

mg/l

0.97

1647

6062

(3024891) Influenza virus A+B Ag [Presence] in Specimen

2000

7014

1.50

56.35

1.2

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1379

4441

1.63

56.12

3.0

3.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

2097

7436

1.49

56.01

3.0

3.4

38.0

46.1

mg/l

1.31

1642

6061

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

1113

3387

1.73

55.87

1.1

1.5

g/l

0.48

1009

3083

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

2044

7231

1.49

55.22

3.0

3.4

4.9

4.5

ratio

0.05

182

570

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

1059

3188

1.74

55.19

6.4

6.2

11.4

11.5

mg/l

0.25

972

2934

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1022

3045

1.76

55.17

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1043

3128

1.75

55.07

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

1076

3259

1.73

54.91

1.5

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1015

3028

1.76

54.56

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1325

4257

1.64

54.43

1.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1009

3014

1.76

54.00

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2573

9558

1.42

53.94

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1008

3012

1.76

53.89

1.4

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3538

13862

1.35

53.86

2.9

2.7

0.3

e6/l

0.00

3435

13499

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1005

3011

1.75

53.26

1.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

552

1343

2.15

53.17

1.4

1.5

6.0

u/l

0.01

461

1126

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1158

3615

1.68

53.06

1.5

1.4

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

683

1806

1.98

53.03

1.1

287.4

452.5

mg/l

0.51

619

1638

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

134

128

5.47

52.56

1.1

1.4

51.9

43.7

mg/l

0.80

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1805

6289

1.51

52.44

1.2

1.3

—

(3017509) Phencyclidine [Presence] in Urine

194

263

3.86

52.02

1.9

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1011

3057

1.74

51.92

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1640

12638

0.67

51.48

1.4

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

491

1154

2.23

51.37

1.2

1.3

63.0

64.1

0.07

140

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

635

1670

1.99

50.08

1.2

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

1015

3109

1.71

49.83

1.5

1.4

—

(3006270) Folate [Moles/volume] in Blood

706

1932

1.92

49.78

1.2

1.1

383.1

358.1

nmol/l

2.15

605

1634

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

631

1661

1.99

49.64

1.2

1.3

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1478

4997

1.55

49.21

1.2

118.3

127.8

titre

0.09

105

(3023419) Bacteria identified in Sputum by Culture

955

2886

1.74

49.16

2.5

—

(3002256) Pathology report gross observation

7990

35016

1.22

49.02

1.3

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

1062

3316

1.68

48.65

1.8

5740.8

2943.6

titre

0.62

146

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1802

6379

1.49

48.52

1.8

1.9

14.0

19.8

iu/l

0.21

623

2400

(3036489) Thrombin time

2640

10037

1.39

48.39

2.0

2.1

21.3

21.5

0.44

2265

8697

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

366

774

2.47

48.20

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2950

20347

0.75

47.65

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1173

3781

1.63

47.61

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

414

935

2.32

47.46

2.6

2.3

—

(3016244) Insulin [Units/volume] in Serum or Plasma

575

1488

2.02

47.40

3.0

3.2

30.4

25.0

mu/l

2.14

537

1389

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

359

759

2.48

47.31

1.3

1.4

14.1

15.5

pmol/l

3.34

294

656

(3039000) Anion gap in Blood

1602

5564

1.51

47.25

7.5

6.6

11.4

11.3

mmol/l

0.94

1465

4996

(3018572) Chloride [Moles/volume] in Blood

1602

5565

1.51

47.21

7.5

6.6

104.7

105.3

mmol/l

4.36

1465

4998

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

517

1290

2.10

46.85

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

411

934

2.30

46.48

1.8

1.7

2.0

1.9

umol/l

1.02

381

882

(3017315) Amylase [Enzymatic activity/volume] in Urine

508

1265

2.10

46.28

1.3

1.2

293.0

339.5

u/l

0.41

469

1188

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

131

140

4.89

46.12

6.6

9.0

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1965

7151

1.45

45.99

1.5

17.2

12.5

iu/ml

0.54

170

(3011985) Renin [Units/volume] in Plasma

1041

3289

1.66

45.66

1.5

1.6

72.7

58.1

mu/l

1.00

910

2968

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1512

5227

1.52

45.57

1.2

4.9

15.1

u/ml

1.37

(3037121) Protein [Mass/volume] in Urine

2334

8796

1.40

45.03

2.9

3.3

0.3

g/l

0.78

1004

4083

(3019230) Fractional oxyhemoglobin in Venous blood

1240

4118

1.58

44.61

3.4

3.0

62.9

65.6

3.74

1231

4102

(3027135) IgG subclass 1 [Mass/volume] in Serum

862

2604

1.74

44.48

1.4

6.5

6.9

g/l

2.01

585

1799

(3024139) IgG subclass 3 [Mass/volume] in Serum

861

2601

1.74

44.43

1.4

0.4

g/l

3.38

585

1801

(3028192) IgG subclass 2 [Mass/volume] in Serum

861

2604

1.73

44.26

1.4

2.8

3.0

g/l

2.62

584

1800

(40760888) Immunoglobulin light chains.free panel - Serum

1592

5600

1.49

44.22

3.0

3.4

—

(4062490)

861

2607

1.73

44.08

1.4

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

394

903

2.28

43.76

1.4

73.1

72.6

0.24

371

861

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

526

1362

2.02

43.35

1.1

1.0

1.1

u/l

1.04

225

628

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

282

552

2.67

43.20

1.4

1.2

130.9

128.3

nmol/l

0.07

204

426

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

495

1255

2.07

43.12

1.1

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

386

886

2.28

42.75

1.4

496.9

757.6

mu/l

1.13

363

844

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1205

4032

1.57

42.01

1.4

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

645

1815

1.86

41.95

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

496

4866

0.53

41.94

1.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

337

734

2.40

41.85

1.6

2.4

0.9

1.1

ug/l

0.71

307

691

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1099

8805

0.65

41.75

1.7

1.8

—

(3036180) Methadone [Presence] in Urine

53.96

41.62

3.0

3.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1500

5285

1.49

41.35

1.2

4.5

6.2

u/ml

0.40

435

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1375

10512

0.68

41.32

1.4

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1041

3379

1.62

41.16

1.5

1.4

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

401

952

2.20

41.11

2.4

2.5

52.7

53.5

umol/l

0.19

332

783

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1884

6948

1.43

41.06

1.9

2.1

10.8

10.9

mg/l

0.29

1760

6501

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

383

894

2.24

40.85

1.8

1.7

28.4

28.9

umol/l

0.45

369

863

(3020717) Zinc [Moles/volume] in Serum or Plasma

459

1155

2.08

40.80

1.6

1.5

22.1

26.8

umol/l

2.47

436

1103

(3042631) Mycobacterium sp identified in Specimen

1003

3234

1.63

40.73

2.7

2.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2198

8340

1.39

40.73

3.3

3.1

0.3

u/ml

0.41

1264

4695

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

9963

45219

1.17

40.69

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1671

6041

1.45

40.50

1.6

1.7

12791.5

13684.1

e6/l

0.32

1174

4454

(3037756) Immunofixation for Serum or Plasma

1402

4900

1.50

40.18

1.6

1.7

—

(3045414) Leukocytes [Presence] in Urine

2936

11682

1.32

40.09

1.9

1.8

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1900

7051

1.42

40.01

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1599

5748

1.46

39.90

1.2

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1515

5404

1.47

39.32

1.3

269.4

260.1

u/ml

0.61

955

3533

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

952

3059

1.63

39.20

1.3

1.4

309.5

282.7

pmol/l

1.11

724

2383

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

861

2697

1.67

39.08

1.6

—

(3019977) pH of Arterial blood

483

1263

2.00

38.83

2.9

2.3

7.4

0.88

166

427

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1825

6764

1.42

38.71

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

822

2567

1.68

37.75

1.5

1.7

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1241

9495

0.68

37.44

1.5

1.6

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

315

701

2.35

37.43

1.2

23.7

20.4

0.24

120

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1292

9808

0.68

37.38

1.3

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1291

9801

0.68

37.36

1.3

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1290

9789

0.68

37.24

1.3

1.5

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

946

3075

1.61

37.24

1.9

2.3

32.6

32.8

0.33

941

3051

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1285

9757

0.68

37.22

1.3

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1530

5531

1.45

37.11

1.4

1.6

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

10.10

36.79

1.1

—

mmol/l

—

(3049717) Cytology report of Urine Cyto stain

2415

9455

1.34

36.77

2.4

2.8

—

(3022621) pH of Urine by Test strip

4129

17371

1.26

36.57

3.2

2.7

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

706

2133

1.73

36.52

1.4

1.3

1.5

1.4

nmol/l

3.09

646

1936

(3006922) Hepatitis E virus Ab [Presence] in Serum

627

1829

1.80

36.49

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

470

1247

1.97

36.36

1.6

1.5

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

5873

25667

1.21

36.35

3.5

4.2

22.7

26.4

ug/l

0.26

4735

20490

(3021788) Differential panel - Synovial fluid

1301

4580

1.49

36.06

1.5

—

(40757494) Bilirubin.total [Moles/volume] in Blood

463

1231

1.97

35.62

2.2

2.1

19.4

27.4

umol/l

0.70

106

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

859

2764

1.63

35.24

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

523

1458

1.88

35.10

1.3

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1408

5066

1.46

35.01

2.2

2.1

0.9

0.8

nmol/l

5.35

1156

4273

(4034850)

2168

8416

1.35

34.89

11.5

8.8

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

496

1369

1.90

34.30

1.3

1.2

5.0

5.4

umol/l

1.16

453

1280

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

206

389

2.77

33.82

1.3

1.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

14960

70719

1.13

33.71

4.2

4.1

21.5

22.0

3.15

6476

33590

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

370

931

2.08

33.02

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1992

7710

1.36

32.67

1.4

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1029

7947

0.67

32.61

1.4

1.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

508

1438

1.85

32.59

1.3

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1855

7104

1.37

32.52

3.1

3.3

1.5

mg/l

0.94

1692

6559

(3044941) Cell count panel - Synovial fluid

1108

3857

1.51

32.45

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

932

7328

0.66

32.35

1.4

1.5

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

549

1597

1.80

32.32

1.6

25.9

25.1

u/ml

0.11

107

313

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

318

760

2.19

32.24

2.5

3.0

27.6

28.9

umol/l

1.09

217

592

(3005033) Fetal Nuchal fold Thickness US

1030

7932

0.67

32.17

1.4

1.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

397

1042

1.99

31.72

2.3

1.8

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1067

8115

0.68

31.20

1.4

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

741

2371

1.64

31.14

1.5

1.8

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

794

2591

1.61

30.87

1.2

62.5

65.4

u/l

0.27

540

1758

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

398

1057

1.97

30.81

1.5

1.6

16.0

5.9

nmol/l

0.34

323

901

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

841

2785

1.58

30.77

1.1

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1454

5398

1.41

30.61

1.5

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

566

1693

1.75

30.41

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

2074

8171

1.33

30.29

2.6

2.7

3.6

g/l

0.65

1963

7815

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2150

8533

1.32

29.86

2.2

2.3

93.2

91.7

2.02

1975

7968

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

566

1703

1.74

29.82

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

2182

8683

1.32

29.74

1.6

1.5

8.0

iu/ml

1.60

433

1849

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

609

1877

1.70

29.48

1.1

1.2

—

(44813793)

603

1859

1.70

29.17

1.1

—

(3017569) Oxygen content in Arterial blood

379

1010

1.96

29.10

2.6

2.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

214

448

2.50

29.03

1.3

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1975

7782

1.33

28.83

2.5

2.6

185.0

185.6

0.11

1864

7393

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

658

2096

1.64

28.20

1.5

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

658

2096

1.64

28.20

1.5

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

658

2096

1.64

28.20

1.5

1.7

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

294

722

2.13

28.00

1.2

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

3529

15024

1.24

27.98

1.7

1.6

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

460

1330

1.81

27.71

1.3

70.3

83.4

titre

0.29

112

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

971

3402

1.50

27.65

1.3

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1086

3896

1.46

27.51

1.3

36.0

36.2

u/l

0.02

948

3410

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

471

1377

1.79

27.38

1.3

596.5

391.2

titre

0.50

104

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

871

2990

1.53

27.30

2.2

2.0

24.5

27.4

mg/l

0.74

252

776

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

287

706

2.13

27.24

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

278

679

2.14

26.86

1.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

1132

4113

1.44

26.86

2.7

3.4

1.3

1.5

0.96

855

3200

(3012920) Ethanol [Mass/volume] in Serum or Plasma

8.25

26.67

1.6

1.1

—

(44790049)

818

2784

1.54

26.67

1.5

—

(44790047)

818

2785

1.54

26.63

1.5

—

(44790048)

818

2786

1.54

26.58

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

704

2317

1.59

26.52

2.7

—

(44806118)

817

2785

1.54

26.45

1.5

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

208

450

2.42

26.44

1.5

1.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

695

2282

1.59

26.43

3.7

3.9

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

2393

9800

1.28

26.38

1.3

218.4

226.5

miu/ml

0.46

1002

4670

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

710

2353

1.58

25.99

1.4

1.6

31.1

30.9

0.05

421

1541

(3039162) Centromere protein B Ab [Units/volume] in Serum

918

3223

1.49

25.92

1.2

50.8

51.4

u/ml

0.02

219

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

697

2304

1.58

25.80

1.4

1.3

112.2

116.5

pmol/l

0.03

305

616

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1578

6128

1.35

25.40

2.3

2.5

128.8

114.2

ug/min

0.50

905

3758

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

438

1286

1.78

25.16

1.6

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

436

1279

1.78

25.12

1.6

1.5

—

(4094501)

1725

6806

1.33

24.99

1.1

—

(4146454)

737

2493

1.55

24.73

2.7

2.8

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

246

592

2.17

24.69

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1504

5827

1.35

24.59

1.4

1.5

21.0

19.8

u/ml

0.09

114

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1515

5878

1.35

24.54

1.4

1.5

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

1121

4143

1.42

24.30

2.1

7.0

6.7

titre

0.05

114

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

385

1100

1.83

24.17

1.3

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

385

1100

1.83

24.17

1.3

1.5

—

(3044927) Protein electrophoresis panel - Urine

679

2271

1.57

23.96

1.2

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

6.87

23.95

1.9

—

(3051611) Lipemic interference index of Serum or Plasma

750

2570

1.53

23.78

3.7

3.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

245

599

2.14

23.69

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

440

1321

1.74

23.50

1.5

1.2

nmol/l

0.01

330

1079

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

230

551

2.18

23.37

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

556

1785

1.63

23.23

2.9

2.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

853

3020

1.48

23.18

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

242

595

2.13

23.10

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

567

1834

1.62

23.00

1.4

11.7

12.5

umol/l

2.02

528

1756

(3008757) Leukocyte morphology finding [Identifier] in Blood

768

2672

1.51

22.72

2.9

3.8

—

(3004616) Nuclear Ab [Presence] in Serum

860

3063

1.47

22.70

1.3

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

240

593

2.12

22.64

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

637

2129

1.57

22.58

1.2

183.8

201.8

titre

0.20

109

355

(3051651) Icteric interference index of Serum or Plasma

474

1473

1.68

22.43

4.0

3.9

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

635

2125

1.56

22.39

1.2

276.2

165.9

titre

0.39

(3001186) Copper [Moles/volume] in Serum or Plasma

226

548

2.16

22.34

1.4

1.3

17.0

16.5

umol/l

0.57

203

495

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

562

1832

1.61

22.12

1.3

1.0

1.3

u/ml

0.43

248

802

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

598

1979

1.58

22.12

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

597

1975

1.58

22.12

1.2

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

491

1547

1.66

22.08

1.9

2.1

99.7

96.8

0.92

453

1441

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

475

1484

1.67

22.05

1.6

1.4

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

597

1977

1.58

22.02

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

267

696

2.01

21.94

2.8

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

267

696

2.01

21.94

2.8

2.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

544

1764

1.61

21.88

1.2

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

2167

8994

1.27

21.47

1.4

1.5

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

341

975

1.83

21.43

1.1

694.3

459.6

ng/l

0.34

233

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1445

5686

1.33

21.38

5.2

5.9

4848.8

1200.1

iu/ml

0.46

165

891

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

589

1959

1.57

21.35

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

588

1955

1.57

21.35

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

589

1960

1.57

21.31

1.2

—

(3045716) Anion gap in Serum or Plasma

360

1050

1.79

21.24

2.4

9.3

9.1

mmol/l

0.40

267

767

(3004451) EKG impression Narrative

377

1121

1.76

20.88

1.3

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1106

4193

1.38

20.77

1.1

13.2

12.0

au/ml

0.18

303

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1375

5410

1.33

20.38

1.4

1.5

109.3

112.5

u/ml

0.37

337

1205

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

524

1715

1.60

20.35

1.2

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

372

1116

1.74

20.02

3.9

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1109

4233

1.37

20.01

1.1

8273.3

841.3

iu/ml

0.44

273

936

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1101

4200

1.37

19.94

1.1

—

(3011412) CD3 cells [#/volume] in Blood

723

2557

1.48

19.84

2.3

2.4

1.2

1.1

e9/l

1.50

433

1529

(3035947) Staphylolysin Ab [Units/volume] in Serum

407

1257

1.69

19.78

1.2

1.1

4.6

3.9

iu/ml

0.24

104

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

874

3210

1.43

19.72

1.5

1.6

58.6

57.0

0.52

523

2143

(3024869) Neuronal Ab [Presence] in Serum

172

393

2.29

19.60

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

470

1515

1.62

19.43

1.5

1.6

4.8

7.1

u/l

2.74

240

739

(3028717) Thiamine [Mass/volume] in Blood

111

204

2.84

19.36

1.1

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

697

2461

1.48

19.30

2.8

3.4

58.4

58.5

0.03

425

1596

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

211

532

2.07

19.02

1.1

1.3

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

442

1412

1.64

18.95

1.2

1.3

26.4

24.8

u/l

0.21

372

1235

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

296

845

1.83

18.78

2.1

2.0

59.5

56.5

ug/l

0.22

290

825

(3012565) Volume of 24 hour Urine

405

1270

1.67

18.65

2.2

1948.6

1972.2

0.15

362

1142

(3019420) Tryptase [Mass/volume] in Serum or Plasma

439

1408

1.63

18.54

1.5

7.9

8.5

ug/l

0.23

395

1276

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

319

937

1.78

18.48

1.0

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

452

1464

1.61

18.37

1.2

1.3

92.4

92.1

u/l

0.02

389

1292

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1120

4345

1.35

18.29

3.3

3.0

0.8

nmol/l

0.17

844

3360

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1100

4261

1.35

18.14

2.5

2.9

1817.6

4841.9

u/ml

0.62

249

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

497

1654

1.57

18.07

1.9

1.7

—

(3032057) Clostridioides difficile [Presence] in Stool

182

443

2.15

17.95

1.7

1.9

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

674

2401

1.47

17.91

1.3

1.4

133822.6

95346.3

e6/l

0.70

471

1614

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1092

4237

1.35

17.83

1.2

3.5

4.0

u/ml

0.95

460

1949

(3011048) Pyruvate [Moles/volume] in Blood

111

3.48

17.69

1.3

1.4

91.0

70.6

umol/l

2.89

100

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

180

440

2.14

17.58

2.5

2.4

7.1

7.6

mmol/l

1.00

116

254

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1045

4041

1.35

17.45

1.1

118.9

116.9

1.16

947

3674

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

3001

13178

1.20

17.41

3.0

3.3

52.4

50.4

u/ml

0.07

2883

12743

(3041806) Other cells [#/volume] in Blood by Manual count

394

1254

1.64

17.20

1.5

1.4

—

(4024509)

642

2286

1.47

17.12

1.7

1.5

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

943

3599

1.37

17.11

2.6

2.9

240.3

737.3

u/ml

1.31

908

3406

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

137

301

2.38

17.07

1.0

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

336

1028

1.71

16.98

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

370

1163

1.66

16.94

1.6

5.1

5.4

mmol/24h

0.18

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1118

4391

1.33

16.86

1.2

1.3

3.4

3.7

u/ml

0.22

352

1576

(4306422)

1081

4227

1.34

16.80

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

1426

5802

1.29

16.67

2.2

2.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

360

2999

0.62

16.64

1.4

1.6

8.3

7.5

mmol/l

5.60

220

1751

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

540

1868

1.51

16.58

2.1

2.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

215

576

1.95

16.55

1.1

—

(3002619) Bacteria identified in Specimen by Culture

191

491

2.03

16.45

1.3

1.2

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

480

1623

1.55

16.36

2.8

3.5

110.2

141.0

nmol/l

1.20

467

1597

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1417

5780

1.28

16.25

1.1

1.3

1.7

u/ml

0.81

597

2310

(3034891) Synovial lining cells/100 cells in Synovial fluid

373

1193

1.63

16.02

1.4

1.5

4.1

4.4

0.07

307

(3045424) Erythrocytes [Presence] in Urine

1132

4500

1.32

15.74

1.5

1.4

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

205

550

1.95

15.74

1.1

6.4

7.3

mg/g

0.87

194

521

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1006

3932

1.34

15.72

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

108

3.34

15.59

1.3

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

112

236

2.48

15.27

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

167

2.78

15.09

1.6

1.7

46.7

45.9

umol/l

0.08

167

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

431

1450

1.55

15.07

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1017

4008

1.33

15.05

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

289

880

1.72

14.93

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

218

609

1.87

14.91

1.2

—

(1175426) CD3 cells/100 lymphocytes in Blood

569

2038

1.46

14.82

2.0

74.6

72.6

2.58

536

1970

(3028679) Herpes simplex virus Ab [Presence] in Serum

451

1539

1.53

14.81

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1142

4587

1.30

14.77

1.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

148

360

2.15

14.73

1.2

1.4

0.3

0.2

nmol/l

0.15

107

262

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

754

2848

1.39

14.65

3.0

3.3

5.7

8.1

nmol/l

0.58

727

2769

(4035726)

4939

22851

1.14

14.57

1.4

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

286

875

1.71

14.55

1.2

112.1

106.9

1.15

258

791

(3001556) Androgen free Index in Serum or Plasma

127

291

2.28

14.53

1.4

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

330

2708

0.63

14.34

1.4

1.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1197

4863

1.29

14.23

1.1

2.2

u/ml

0.01

320

1206

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

1021

4061

1.32

14.20

1.1

2.8

3.1

u/ml

0.33

452

2060

(3020876) Protein [Mass/time] in 24 hour Urine

589

2143

1.44

14.16

1.9

2.0

1.4

1.0

g/24h

0.59

126

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

385

1281

1.57

14.15

1.1

1681.2

1482.2

miu/ml

2.48

385

1281

(3003888) Timothy IgE Ab [Units/volume] in Serum

1265

5180

1.28

14.14

1.1

5.6

6.0

u/ml

0.39

654

2671

(3033923) Metanephrine [Moles/time] in 24 hour Urine

170

444

2.00

14.12

1.1

3.9

umol/24h

0.42

219

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

281

863

1.70

14.12

1.1

92.6

90.0

0.68

126

415

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

202

561

1.88

14.10

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

632

2332

1.42

14.08

2.1

43.6

39.2

1.72

287

(3029075) Extractable nuclear Ab panel - Serum

244

720

1.77

14.07

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

212

600

1.85

13.98

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

522

1861

1.47

13.95

1.8

1.4

66.5

71.7

umol/l

0.85

165

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

172

2.67

13.91

1.5

1.3

10.0

16.0

pmol/l

0.94

144

(3016330) Potassium [Moles/time] in 24 hour Urine

145

359

2.11

13.85

1.3

84.8

79.5

mmol/24h

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

516

1840

1.47

13.79

2.4

2.5

515.0

534.8

e6/l

0.29

414

1559

(3000012) Reticulocyte production index

396

1335

1.55

13.78

1.4

1.6

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

536

1926

1.46

13.77

2.5

808.0

693.2

e6/l

0.96

208

799

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1204

4918

1.28

13.74

1.1

1.2

1.1

u/ml

0.27

505

2054

(3019832) Treponema pallidum Ab [Presence] in Serum

7261

34487

1.11

13.67

1.8

1.7

—

(3024263) Appearance of Synovial fluid

390

1314

1.55

13.61

1.6

1.8

—

(3006576) Bicarbonate [Moles/volume] in Blood

279

865

1.69

13.57

5.7

6.3

25.0

mmol/l

0.07

257

778

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

273

842

1.69

13.54

1.1

96.4

90.0

1.57

126

405

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

816

3165

1.35

13.49

1.1

2.2

iu/ml

2.52

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

360

1194

1.58

13.45

1.1

8.1

11.1

u/ml

0.76

214

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

273

845

1.69

13.37

1.3

1.2

111.3

110.9

0.10

247

753

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

130

313

2.17

13.31

1.2

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

111

250

2.32

13.24

1.1

1.0

—

(3038026) Centromere Ab [Units/volume] in Serum

548

1996

1.44

13.14

1.2

80.6

38.8

u/ml

1.16

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

109

245

2.32

13.07

1.1

1.0

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

117

272

2.25

13.01

2.2

3.4

37.4

43.8

umol/l

2.09

104

223

(3025130) Human papilloma virus identified in Specimen

948

3781

1.31

12.98

1.6

1.7

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

371

1251

1.55

12.93

1.8

2.0

142.9

142.8

0.01

343

1179

(3020491) Glucose [Moles/volume] in Blood

544

1986

1.43

12.90

1.9

1.7

7.1

6.5

mmol/l

2.97

403

1457

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

482

1720

1.47

12.87

1.1

1.2

—

(3010503) CD19 cells [#/volume] in Blood

453

1597

1.48

12.85

2.5

0.2

0.4

e9/l

0.85

432

1566

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

517

1871

1.44

12.84

1.2

8.0

11.3

u/ml

0.32

120

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

535

1949

1.44

12.83

1.2

73.1

68.6

u/ml

0.12

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

131

322

2.12

12.78

1.0

79.6

80.9

ug/l

0.12

105

265

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

162

432

1.96

12.77

2.5

2.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

988

3974

1.30

12.73

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

760

2948

1.35

12.60

1.4

1.6

27.9

36.0

iu/ml

0.83

134

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

535

1956

1.43

12.60

1.2

50.3

46.8

u/ml

0.11

144

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

549

2021

1.42

12.46

2.0

13.5

14.2

0.59

256

929

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

499

1807

1.44

12.38

1.5

1.4

12.2

12.9

u/l

1.75

477

1750

(3039443) Prostate specific Ag panel - Serum or Plasma

837

5689

0.76

12.24

1.6

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

128

318

2.10

12.19

1.2

1.3

48.8

54.6

0.55

154

(4015189)

206

605

1.78

12.15

2.2

2.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

129

322

2.09

12.14

1.2

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

715

2768

1.35

12.04

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

286

927

1.61

11.82

1.3

1.2

0.3

g/l

0.22

233

730

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

369

1278

1.51

11.47

1.1

22.3

26.6

u/l

0.81

277

987

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

151

409

1.93

11.45

1.1

1.4

70.7

291.5

ng/l

0.61

286

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

369

1279

1.51

11.43

1.1

82.0

88.0

u/l

0.68

293

1021

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

133

346

2.01

11.28

2.5

2.3

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

488

1793

1.42

11.25

2.4

2.5

0.2

e9/l

0.04

412

1561

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

758

2995

1.32

11.17

1.1

97.2

95.4

0.98

713

2810

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

401

1423

1.47

11.10

1.9

1.7

2.4

2.6

u/field

0.17

290

1006

(3045683) HLA typing for celiac disease panel - Blood or Tissue

458

1671

1.43

10.99

1.0

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

402

1431

1.47

10.96

2.2

2.6

843.5

1132.3

u/ml

1.49

396

1412

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

474

1743

1.42

10.90

1.1

ratio

0.31

179

608

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

148

407

1.90

10.77

1.2

1.1

—

(3028433) Virus identified in Specimen by Culture

255

823

1.62

10.77

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

188

559

1.76

10.72

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

963

3953

1.27

10.69

1.1

6.9

4.7

u/ml

1.34

427

1654

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

303

1022

1.55

10.66

1.9

—

(40762365) Oxygen content in Arterial blood by calculation

141

384

1.92

10.57

3.0

15.0

14.7

ml/dl

0.54

133

358

(21491868) Cryoglobulin [Mass/volume] in Serum

264

864

1.60

10.56

1.2

0.8

0.4

g/l

0.38

(3013166) Neutrophils/100 leukocytes in Synovial fluid

236

751

1.64

10.55

1.3

1.4

50.0

57.2

1.85

197

644

(40757373) Influenza virus identified in Isolate

164

470

1.82

10.55

1.6

1.7

—

(40768793) Breast Pathology biopsy report

1270

5393

1.23

10.52

1.3

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1020

4226

1.26

10.51

1.1

4.3

4.4

u/ml

0.08

413

1678

(3010015) Selenium [Moles/volume] in Serum or Plasma

165

2.44

10.31

2.2

1.9

1.3

umol/l

0.36

146

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

369

1309

1.47

10.28

1.6

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

369

1309

1.47

10.28

1.6

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

369

1309

1.47

10.28

1.6

1.9

—

(3012441) Differential panel - Pleural fluid

646

2526

1.34

10.27

1.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

446

1641

1.42

10.26

1.1

7.5

8.5

iu/ml

0.28

100

446

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

173

509

1.77

10.24

1.6

0.4

ug/l

0.20

114

330

(3022493) Free Hemoglobin [Mass/volume] in Plasma

330

1145

1.51

10.23

3.0

5.7

1342.1

3191.4

mg/l

0.95

230

807

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

613

2380

1.35

10.22

3.9

5.1

80.7

118.0

u/ml

0.72

160

794

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

2023

9004

1.18

10.18

3.1

3.6

724.0

1502.3

u/ml

1.18

1699

7767

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1063

4444

1.25

10.16

1.2

—

(3011897) Casein IgE Ab [Units/volume] in Serum

142

394

1.88

10.10

1.1

1.2

16.5

6.0

u/ml

0.48

(3003434) Protein [Mass/volume] in Pleural fluid

814

3298

1.29

10.05

1.5

33.3

32.9

g/l

0.32

734

2977

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

145

2.52

10.05

1.2

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1194

5069

1.23

9.94

3.1

3.4

602.8

947.7

u/ml

0.59

1076

4620

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

367

1310

1.46

9.93

1.6

1.9

—

(3000093) Morphology [Interpretation] in Blood Narrative

635

2490

1.33

9.93

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

413

1513

1.43

9.76

1.2

—

(3000330) Specific gravity of Urine by Test strip

2847

13048

1.14

9.73

3.8

3.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

276

932

1.55

9.71

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

292

999

1.53

9.70

1.7

2.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

364

1304

1.46

9.68

1.1

1.2

24.4

11.5

u/ml

0.52

142

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

292

1000

1.53

9.65

1.7

2.1

—

(3000034) Microalbumin [Mass/volume] in Urine

598

2337

1.34

9.58

2.9

3.0

43.9

60.7

mg/l

1.07

437

1674

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

349

1245

1.46

9.50

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

128

351

1.90

9.46

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

735

2963

1.30

9.46

1.5

4209.9

2566.1

e6/l

0.64

533

2154

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

104

265

2.05

9.41

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

163

485

1.75

9.34

1.5

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

294

1017

1.51

9.30

1.7

2.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

179

549

1.70

9.24

1.2

348.8

299.8

pmol/l

0.22

126

406

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

246

821

1.57

9.14

2.0

1.9

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

233

770

1.58

9.04

1.1

2.1

17.3

u/ml

0.62

132

421

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

245

2.07

9.00

2.3

2.1

—

(40768806) Pleura Pathology biopsy report

635

2529

1.31

8.97

1.5

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

132

373

1.85

8.95

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

750

3055

1.28

8.95

1.8

1.9

23.3

23.6

ug/l

0.04

733

2996

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

225

2.11

8.91

2.2

2.6

0.7

1.2

mmol/l

1.92

153

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

332

1190

1.46

8.86

2.1

113.0

83.3

ug/min

0.45

278

(3051339) Copper [Moles/volume] in Blood

105

2.68

8.78

1.2

1.4

16.7

16.1

umol/l

0.44

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.15

8.67

1.0

—

(3051593) INR in Capillary blood by Coagulation assay

317

1131

1.46

8.67

6.7

11.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

635

2545

1.30

8.59

2.0

2.1

—

(37021550) Renin [Units/volume] in Plasma --upright

160

486

1.72

8.59

1.3

102.6

65.5

mu/l

0.37

120

365

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

186

589

1.65

8.58

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

186

589

1.65

8.58

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

186

589

1.65

8.58

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

186

589

1.65

8.58

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

220

728

1.58

8.52

2.1

2.0

146.1

532.9

e6/l

2.08

122

379

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1453

6389

1.19

8.51

1.3

1.2

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

560

2210

1.32

8.47

4.1

3.7

41.7

52.2

u/ml

0.58

554

2179

(3008037) Lactate [Moles/volume] in Venous blood

1289

5609

1.20

8.47

3.7

3.0

1.7

1.6

mmol/l

2.40

1265

5501

(3042111) Morphology [Interpretation] in Bone marrow Narrative

965

4078

1.24

8.47

1.5

1.7

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

665

2692

1.29

8.36

1.5

69024.1

51480.1

e6/l

0.56

410

1609

(3006245) CD3-CD19+ cells/100 cells in Blood

288

1016

1.48

8.36

2.1

8.4

10.8

3.55

268

942

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

3.82

8.28

1.5

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

10429

51337

1.07

8.27

2.9

0.7

0.8

ug/l

15.26

6887

32702

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

267

931

1.50

8.21

1.9

2.0

165.1

167.5

0.13

246

881

(3014148) Varicella zoster virus Ab [Titer] in Serum

921

3888

1.24

8.18

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

108

295

1.91

8.15

2.1

1.9

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

748

3087

1.27

8.09

2.8

2.3

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

341

1253

1.42

8.03

1.0

1.1

97.7

96.6

0.26

271

1007

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

101

271

1.95

8.02

1.1

—

(3034988) Calcium [Moles/volume] in Capillary blood

140

418

1.75

8.01

1.7

1.8

1.2

mmol/l

0.36

135

399

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

278

984

1.48

7.96

2.5

2.3

—

(3033942) Copper [Moles/time] in 24 hour Urine

102

2.61

7.92

1.2

0.9

1.0

umol/24h

0.02

(3036782) Glucose [Moles/volume] in Pleural fluid

581

2334

1.30

7.78

1.3

6.5

6.2

mmol/l

1.18

533

2171

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.66

7.75

1.1

1.2

272.9

338.5

u/l

0.48

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

884

3739

1.24

7.74

3.8

3.4

32.0

39.1

u/ml

0.94

857

3592

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

183

595

1.61

7.67

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

227

777

1.53

7.64

1.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

208

699

1.55

7.60

1.5

1.6

9.3

9.0

ug/l

0.40

208

699

(4268621)

705

2915

1.26

7.55

2.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

295

1069

1.44

7.53

2.7

2.9

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

254

894

1.48

7.51

1.1

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

2.61

7.47

1.1

1.2

1.4

0.58

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

792

0.53

7.46

1.2

—

(3016228) CD19 cells/100 cells in Blood

294

1067

1.44

7.45

2.0

8.6

8.2

0.25

280

1050

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

405

1554

1.36

7.44

2.8

42.0

38.9

1.50

123

529

(3030313) Adrenal Ab [Titer] in Serum

239

1.97

7.40

1.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

557

2242

1.30

7.38

1.4

1.3

567.3

454.5

u/l

0.52

522

2129

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

103

288

1.87

7.31

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

215

736

1.53

7.26

1.8

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

170

2.15

7.25

1.1

6.5

11.5

u/l

1.74

170

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

521

2084

1.31

7.24

2.2

1.9

2.1

2.3

u/field

0.20

238

880

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

143

2.26

7.23

1.3

1.5

12.4

0.01

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

278

1005

1.44

7.21

2.0

28.3

29.8

1.00

261

952

(3016750) Collection duration of Urine

395

1519

1.36

7.18

2.0

2.2

514.4

496.4

min

2.61

287

1159

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

164

2.16

7.16

1.3

1.4

38.7

35.8

0.20

107

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

173

566

1.60

7.11

1.2

88.2

89.1

0.07

170

(3037556) Urate [Mass/volume] in Serum or Plasma

203

690

1.54

7.09

1.4

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

102

2.51

7.09

1.5

1.6

0.1

0.2

u/l

0.15

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

107

307

1.82

7.03

1.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

186

621

1.56

7.03

1.1

—

(3017704) Immunofixation for Urine

348

1316

1.38

7.02

1.7

1.6

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

135

416

1.69

6.99

1.3

1.4

5.9

7.0

nmol/l

0.52

126

401

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

172

565

1.59

6.97

1.2

77.8

76.9

0.05

163

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

260

1.89

6.91

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

109

965

0.59

6.84

3.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

174

576

1.58

6.84

1.8

2.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

109

964

0.59

6.82

6.4

6.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

398

1549

1.34

6.73

1.2

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

197

2.01

6.71

1.6

2.1

1.6

mg/l

0.35

124

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

800

3405

1.23

6.68

1.1

1.0

0.7

0.4

u/ml

0.37

184

670

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

178

596

1.56

6.68

1.1

1.3

113.0

107.0

1.41

167

562

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.57

6.64

1.3

3.3

2.9

2.0

mu/l

0.39

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.68

6.42

1.1

1.0

—

(21494814) CD8 cells/100 lymphocytes in Specimen

283

1051

1.41

6.40

2.0

—

(3045788) Cell count panel - Pleural fluid

558

2292

1.27

6.39

1.6

1.5

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

131

2.23

6.38

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

580

2395

1.27

6.37

1.3

1.4

—

(3020071) Venlafaxine [Mass/volume] in Serum or Plasma

+∞

6.35

1.0

0.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

216

1.93

6.35

1.2

1.1

1.9

3.4

umol/24h

0.44

216

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

231

1.90

6.32

1.2

1.1

—

(40768441) Liver Pathology biopsy report

473

1906

1.30

6.30

1.4

—

(3003129) Base excess in Capillary blood by calculation

175

593

1.54

6.26

2.0

1.6

0.6

0.2

mmol/l

0.62

164

557

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

160

2.09

6.23

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

113

343

1.72

6.22

1.7

1.6

—

(3036670) Protein [Mass/volume] in Synovial fluid

204

717

1.49

6.17

1.2

39.0

40.9

g/l

1.08

117

395

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

175

2.03

6.16

3.0

54.4

406.2

pmol/l

0.49

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

456

1839

1.30

6.06

1.8

1.7

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

203

717

1.48

6.01

1.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

484

1970

1.28

6.00

1.9

1.8

3.3

3.9

mg/l

2.26

452

1887

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

192

1.96

5.94

1.6

1.9

1.5

mg/l

0.25

112

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

192

1.96

5.94

1.6

2.5

1.8

mg/l

0.45

136

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

192

1.96

5.94

1.6

2.3

1.7

mg/l

0.29

113

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

192

1.96

5.94

1.6

0.8

0.7

mg/l

0.09

121

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

192

1.96

5.94

1.6

2.7

3.0

mg/l

0.17

137

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

192

1.96

5.94

1.6

4.0

4.5

mg/l

0.21

121

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

192

1.96

5.94

1.6

2.8

2.0

mg/l

0.48

137

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

192

1.96

5.94

1.6

2.8

2.1

mg/l

0.31

125

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

192

1.96

5.94

1.6

2.8

2.1

mg/l

0.53

129

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

172

589

1.52

5.90

1.1

1.2

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

173

1.99

5.72

1.1

1.2

11.8

26.0

1.09

(3010370) Gastrin [Moles/volume] in Serum or Plasma

119

376

1.65

5.71

1.9

1.7

45.8

50.9

pmol/l

0.24

102

312

(3052592) Norovirus Ag [Presence] in Stool

144

480

1.57

5.59

1.2

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

318

1236

1.34

5.52

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

124

400

1.62

5.51

1.2

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

124

2.15

5.37

1.1

1.4

1.1

2.1

0.84

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.74

5.37

1.1

1.3

—

(44806071)

111

351

1.65

5.34

1.0

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

186

1.91

5.27

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

135

450

1.57

5.27

2.4

2.6

37.2

62.6

mg/l

0.89

(3020911) Cortisol [Moles/time] in 24 hour Urine

3.38

5.26

1.1

108.2

100.2

nmol/24h

0.12

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

220

1.83

5.25

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

114

365

1.63

5.24

1.2

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

123

402

1.60

5.21

1.1

—

(3038515) Glucose [Moles/volume] in Venous blood

1181

5331

1.16

5.21

3.9

3.1

7.7

7.5

mmol/l

0.68

1162

5241

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1300

5921

1.15

5.08

1.4

117.8

128.7

pmol/l

0.28

1256

5778

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

135

2.05

5.00

1.2

1.1

1.2

u/field

0.53

(3004775) Volume in Urine collected for unspecified duration

496

2075

1.25

4.99

2.1

2.3

708.3

672.9

0.83

339

1436

(4212803)

205

1.83

4.98

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

234

882

1.39

4.97

1.5

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

287

1.69

4.93

1.0

0.2

0.3

u/ml

0.42

177

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

143

492

1.52

4.89

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

106

341

1.62

4.82

1.0

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

435

1804

1.26

4.74

1.3

14.8

13.9

u/l

0.28

403

1663

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

301

1190

1.32

4.73

1.9

2.3

23.1

252.6

ug/l

1.80

278

1140

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.46

4.72

1.0

164.7

210.3

pmol/l

0.39

(3036603) Volume of Urine

430

1783

1.26

4.70

1.6

1.7

2105.0

1926.8

0.91

443

(3051387) C reactive protein [Mass/volume] in Capillary blood

1287

5896

1.14

4.66

4.2

3.0

26.1

27.1

mg/l

0.45

766

3770

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

143

1.97

4.63

1.1

1.7

2.9

u/l

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

220

833

1.38

4.59

2.9

3.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

162

1.90

4.58

1.1

12.4

13.8

nmol/l

—

(3036071) Salmonella sp Ab [Titer] in Serum

231

885

1.36

4.50

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

309

1237

1.30

4.47

2.9

3.4

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

149

529

1.47

4.43

5.0

6.1

65.8

71.5

1.64

112

425

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1967

9273

1.11

4.43

1.5

1.4

—

(3035880) pH of Pleural fluid

333

1349

1.29

4.42

1.3

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

157

1.89

4.40

1.4

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

139

1.95

4.37

1.2

1.0

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

150

536

1.46

4.33

1.0

0.4

2.3

u/ml

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

215

1.75

4.33

1.0

1.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

222

851

1.36

4.32

1.4

58.3

63.0

1.05

179

696

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

301

1211

1.30

4.23

1.4

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

300

1211

1.29

4.12

1.4

1.5

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

135

1.93

4.11

1.0

1.1

41.6

49.7

u/l

0.52

104

(4211845)

345

1419

1.27

4.10

3.1

2.9

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

231

900

1.34

4.08

2.1

1.6

56713.9

17582.1

u/ml

0.42

109

(36303858) Crystals [Presence] in Urine

3.10

4.06

1.2

1.1

—

(3013466) aPTT in Blood by Coagulation assay

155

1.85

4.00

1.1

35.9

37.7

1.11

128

(3050794) Legionella sp Ab [Presence] in Serum

215

1.70

3.87

1.1

—

(3006462) Nitrate [Presence] in Urine

314

1289

1.27

3.82

3.2

3.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

112

389

1.50

3.77

1.6

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

3.17

3.77

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

241

1.65

3.75

1.1

1.3

5.5

6.7

mmol/l

0.81

124

(3007916) DNA double strand Ab [Titer] in Serum

327

1.55

3.74

1.3

346.4

117.7

titre

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

2.39

3.70

1.1

1.2

323.7

438.0

pmol/l

0.40

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

199

771

1.35

3.69

2.3

1.7

9752.3

14010.3

e6/l

0.41

107

409

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

183

1.74

3.67

1.2

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.14

3.66

1.1

1.2

1650.2

4804.8

ng/l

1.33

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

2100

11940

0.91

3.65

1.9

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

221

872

1.32

3.64

2.4

1.9

5181.8

3401.1

e6/l

0.22

146

601

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

149

1.82

3.63

1.0

19.9

19.2

u/ml

0.03

126

(40763480) Human metapneumovirus Ag [Presence] in Specimen

116

1.93

3.59

1.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

3.06

3.59

1.1

148.3

139.7

mmol/24h

0.22

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

223

1513

0.77

3.58

1.2

1.3

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

179

687

1.36

3.55

1.4

1.3

37.7

38.2

0.07

123

468

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

106

370

1.50

3.52

1.4

201340.0

243233.5

nmol/l

0.09

310

(44786800) Granulocytes/100 leukocytes in Body fluid

291

1.56

3.50

1.3

1.4

22.5

24.4

0.18

226

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

316

1.54

3.49

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

113

401

1.47

3.47

1.1

2.8

8.1

pmol/l

0.67

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

104

363

1.50

3.46

1.1

0.5

0.2

u/ml

0.36

233

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

113

402

1.47

3.43

1.5

1.6

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

211

1.66

3.43

1.2

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.27

3.36

1.0

—

(3047189) Immunofixation for 24 hour Urine

270

1108

1.27

3.35

1.9

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

139

517

1.40

3.34

1.4

1.2

46.5

41.7

mg/l

0.05

105

368

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.30

3.32

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

253

1.57

3.15

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

141

1.78

3.15

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

428

1862

1.20

3.13

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

113

412

1.43

3.07

4.9

5.1

51.6

45.4

ug/min

0.34

328

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

198

1.63

3.05

1.2

108.2

109.1

ug/l

0.01

124

(37019676) Renin [Units/volume] in Plasma --supine

2.43

3.03

1.0

1.1

59.5

67.6

mu/l

0.07

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

2.48

3.00

1.5

1.2

93.1

62.4

e6/l

0.21

(21494567) Legionella sp IgM Ab [Presence] in Serum

179

1.66

2.99

1.1

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

2.61

2.96

1.0

9474.4

13236.0

ng/l

—

(1617658) Protocol used for examination of sentinel lymph nodes

399

1736

1.20

2.94

1.0

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

180

1.65

2.94

1.0

1.3

0.8

u/ml

0.19

119

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.38

2.91

1.0

1.1

1.9

2.9

1.21

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

185

1.64

2.89

1.2

1.1

—

(3003694) ABO and Rh group [Type] in Blood

16618

84649

1.03

2.87

1.5

—

(3029396) Erythrocyte agglutination [Presence] in Blood

151

1041

0.76

2.83

2.7

3.0

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

117

437

1.40

2.81

1.2

1.4

250.3

144.3

titre

0.26

(3002331) Protein [Mass/volume] in Peritoneal fluid

143

553

1.35

2.79

1.6

1.3

36.8

36.7

g/l

0.00

444

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

151

1.69

2.78

1.0

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

119

447

1.39

2.78

1.3

1.2

1.6

1.7

mmol/l

0.12

277

(3032743) Legionella sp IgG Ab [Presence] in Serum

175

1.64

2.78

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

254

1.52

2.74

1.0

1.1

1.4

u/ml

0.09

185

(3011841) English Walnut IgE Ab [Units/volume] in Serum

248

1.52

2.64

1.0

0.2

0.9

u/ml

0.88

181

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

321

1.45

2.62

3.0

2.3

0.6

0.5

u/field

0.33

321

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.36

2.61

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.01

2.59

1.3

1.2

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

1.85

2.58

1.1

1.9

0.9

u/field

0.59

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.07

2.57

1.0

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

167

1.62

2.56

1.0

0.1

2.5

u/ml

1.76

133

(3016031) Almond IgE Ab [Units/volume] in Serum

167

1.62

2.56

1.0

0.3

0.4

u/ml

0.53

(3001893) Eosinophils/100 leukocytes in Pleural fluid

183

744

1.28

2.55

1.4

3.4

2.6

0.51

146

624

(3026692) Albumin [Mass/volume] in Peritoneal fluid

158

630

1.31

2.55

1.6

1.3

12.2

13.9

g/l

1.30

110

483

(44806420)

163

653

1.30

2.54

2.3

2.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

428

1903

1.17

2.53

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

1416

6776

1.09

2.52

5.0

3.8

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

216

898

1.26

2.52

1.1

1.0

10.3

12.4

u/ml

0.24

116

(3034274) Bile acid [Moles/volume] in Serum --fasting

920

4310

1.12

2.51

2.0

2.2

6.5

6.9

umol/l

0.27

674

3178

(3013727) Leukocytes other/100 leukocytes in Blood

211

875

1.26

2.51

2.9

3.6

53.5

52.6

0.23

206

840

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

290

1.46

2.49

1.3

1.2

—

(3033799) Differential panel - Peritoneal fluid

185

756

1.28

2.49

2.3

1.9

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

167

674

1.29

2.47

1.3

283.0

256.0

ug/l

0.06

365

(3035082) Kappa light chains [Mass/volume] in Urine

2.11

2.47

1.1

0.4

0.0

g/l

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

247

1046

1.23

2.45

1.9

2.0

8.4

9.5

mg/l

2.16

197

835

(3035611) Eosinophils/100 leukocytes in Synovial fluid

165

1.61

2.45

1.4

1.8

0.9

0.5

0.54

127

(3027974) Hepatitis B virus e Ag [Presence] in Serum

157

1.63

2.45

1.5

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

129

1.70

2.45

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

122

472

1.35

2.43

1.1

1.6

3.4

u/ml

0.81

329

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

102

1.79

2.43

1.5

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

2.13

2.42

1.5

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.96

2.42

1.1

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

154

1.63

2.39

1.3

25.1

15.2

pmol/l

0.74

132

(3017461) Flecainide [Moles/volume] in Serum or Plasma

138

1.66

2.39

1.4

1.7

0.8

0.7

umol/l

0.69

103

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

306

1.43

2.38

2.0

1.7

1.8

1.7

mg/l

0.39

255

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

205

1.53

2.32

1.1

5.3

20.7

iu/ml

2.79

(3023383) Lactate [Moles/volume] in Pleural fluid

186

770

1.26

2.29

1.4

1.3

4.1

3.4

mmol/l

1.56

171

710

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

257

1.46

2.28

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

196

1266

0.81

2.24

1.2

1.3

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

274

1186

1.21

2.23

3.0

8.1

7.8

mg/l

0.24

214

960

(3020650) Glucose [Presence] in Urine

183

759

1.26

2.22

1.6

1.4

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

154

1.59

2.19

1.5

1.4

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

147

595

1.29

2.18

1.5

1.4

25.1

21.5

0.78

129

488

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

102

1.74

2.18

1.3

1.1

1.0

u/field

0.19

(3020874) Milk IgE Ab [Units/volume] in Serum

402

1804

1.16

2.17

1.0

1.1

4.7

2.3

u/ml

0.39

116

479

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

212

898

1.23

2.15

1.0

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

2.01

2.15

1.0

0.2

0.7

u/ml

0.88

(3035933) Granulocytes/100 leukocytes in Blood

179

745

1.25

2.13

1.6

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

322

1974

0.85

2.12

1.2

1.3

1.5

g/l

2.57

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

270

1.43

2.12

2.9

3.1

1.1

1.3

mg/l

0.44

181

(3001729) Color of Synovial fluid

198

1.50

2.08

1.4

1.7

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

250

1082

1.21

2.07

2.5

195.6

134.0

au/ml

0.94

141

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

254

1.44

2.07

1.1

22.1

19.8

u/l

0.35

165

(3015183) Erythrocyte sedimentation rate

337

1499

1.17

2.06

1.2

—

(3007147) Virus identified in Stool by Electron microscopy

3.48

2.04

1.0

—

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

2.13

2.03

1.0

0.0

0.1

u/ml

0.44

(40768800) Prostate Pathology biopsy report

952

5437

0.91

2.01

1.2

—

(3044336) Cobalt [Moles/volume] in Urine

0.34

1.99

1.4

2.5

4.7

24.7

nmol/l

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

371

1.35

1.99

1.2

1.3

—

20.8

—

(40768795) Lymph node Pathology biopsy report

565

2615

1.13

1.99

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

154

1.56

1.99

1.2

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

303

1343

1.18

1.95

1.9

1.8

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

359

1.35

1.95

1.4

1.2

0.7

1.4

mmol/l

1.32

225

(3014599) Egg white IgE Ab [Units/volume] in Serum

395

1788

1.15

1.94

1.0

2.6

2.3

u/ml

0.06

424

(3019768) Coxiella burnetii Ab [Presence] in Serum

151

1.55

1.93

1.1

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

333

1.36

1.93

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

131

1.59

1.90

1.2

1.1

—

(3044007) Cell count panel - Peritoneal fluid

168

705

1.24

1.90

2.3

1.8

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.76

1.90

1.1

237.6

272.5

nmol/l

0.53

(43055442) Apixaban [Mass/volume] in Serum or Plasma

312

1.37

1.89

1.5

1.6

102.0

112.0

ug/l

0.38

257

(3020618) Glucose [Moles/volume] in Synovial fluid

1.74

1.83

1.0

1.1

5.0

5.6

mmol/l

0.35

(3011544) Albumin [Mass/volume] in Pleural fluid

226

1.43

1.83

1.1

17.3

g/l

0.00

210

(3021162) Amylase [Enzymatic activity/volume] in Specimen

101

400

1.32

1.81

2.9

2.8

1319.8

1588.8

u/l

0.14

360

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

312

1397

1.17

1.80

7.4

5.6

653.0

4327.7

u/ml

0.79

254

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

125

1.59

1.79

1.1

1.0

—

(3045142) Bone marrow Pathology biopsy report

600

2810

1.11

1.77

1.3

—

(3011324) Intrinsic factor Ab [Units/volume] in Serum

3.32

1.77

1.0

53.4

26.3

au/ml

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

2.41

1.76

1.1

1.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

282

0.65

1.75

1.1

1.0

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.09

1.74

1.2

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

113

458

1.29

1.73

2.8

5.3

80.1

54.0

u/l

0.35

183

(3012898) Urea [Moles/volume] in Urine

264

1.38

1.73

1.6

1.4

169.7

165.2

mmol/l

0.11

236

(3015076) Soybean IgE Ab [Units/volume] in Serum

359

1631

1.15

1.72

1.0

0.6

0.8

u/ml

0.16

216

(3034426) Prothrombin time (PT)

219

956

1.20

1.72

1.2

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

225

1.41

1.71

1.1

1.2

11.1

9.0

mg/l

0.60

209

(3018001) Oat IgE Ab [Units/volume] in Serum

199

1.44

1.70

1.1

1.0

0.3

1.2

u/ml

0.58

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

221

1.42

1.69

1.0

—

(21494434) Karyotype in Bone marrow

467

2163

1.13

1.68

1.2

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

4.35

1.67

1.4

1.0

—

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

4.35

1.67

2.0

2.3

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

4.35

1.67

1.4

1.0

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

4.35

1.67

1.4

1.0

—

(3042628) Porphyrins [Moles/volume] in Urine

3.48

1.63

1.2

1.0

—

(3034614) HLA Ag [Interpretation]

1.83

1.62

1.5

1.1

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.97

1.62

1.0

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.79

1.61

1.3

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

317

1.33

1.61

2.5

2.7

—

(3036005) Urine sediment comments by Light microscopy Narrative

2.39

1.60

1.1

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

146

1.50

1.60

1.4

1.3

1885.5

925.5

u/l

0.30

133

(3014891) Appearance of Pleural fluid

336

1.32

1.59

1.7

1.6

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

251

1.37

1.58

1.3

2.3

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

155

1.48

1.58

1.0

0.1

0.8

u/ml

1.51

141

(3000919) Neutrophils/100 leukocytes in Pleural fluid

157

671

1.22

1.56

1.4

28.7

20.2

2.73

144

602

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

2.48

1.56

1.1

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

123

512

1.25

1.56

1.9

2.3

—

(40763791) Oxygen content in Venous blood by calculation

1.74

1.54

6.3

5.4

12.8

12.1

ml/dl

0.28

(3011325) HIV 1+2 Ab [Presence] in Serum

152

1.48

1.52

1.1

1.0

—

(3027035) Albumin [Mass/time] in 24 hour Urine

235

1.38

1.52

1.4

1.3

322.8

405.1

mg/24h

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

366

1.30

1.52

1.2

1.3

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

321

1.32

1.50

2.8

2.5

24.9

22.4

mg/l

0.82

302

(3000219) Insulin receptor Ab [Presence] in Serum

3.73

1.50

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.30

1.49

1.0

—

(4133840)

142

901

0.82

1.48

1.2

—

(1761868) Lipid panel - Serum or Plasma

20023

105908

0.98

1.48

2.9

2.6

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

313

1.32

1.47

2.8

2.6

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

312

1856

0.88

1.47

1.3

1.4

29.8

32.3

nmol/l

0.80

276

1733

(3013336) Amino acids [Identifier] in Serum or Plasma

2.03

1.45

3.2

2.8

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

420

1956

1.12

1.43

1.3

1.2

—

(46235168) Fasting glucose [Moles/volume] in Blood

396

0.74

1.42

5.6

1.3

7.7

7.1

mmol/l

0.66

134

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

1.67

1.42

5.3

6.2

1.5

1.2

mg/l

0.33

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.69

1.42

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

399

1.27

1.39

2.1

2.0

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

780

4406

0.92

1.39

3.3

2.3

13.2

13.1

2.04

770

4348

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

191

844

1.18

1.38

1.7

130.3

126.7

au/ml

0.03

(3044590) Delta aminolevulinate [Moles/volume] in Urine

2.85

1.36

1.0

13.8

13.6

umol/l

—

(36304079) Mucus [Presence] in Urine sediment

2.85

1.36

1.2

1.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

368

1.28

1.36

1.4

7.1

12.5

1.88

182

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

2.61

1.36

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

139

599

1.21

1.33

1.2

1.1

44.4

66.0

u/ml

3.66

134

583

(3007919) Fasciola sp Ab [Titer] in Serum

1.85

1.32

1.0

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

166

1.41

1.32

1.0

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

140

1.45

1.32

1.0

1.3

—

438.6

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.99

1.30

1.2

1.3

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

119

1.49

1.30

1.2

0.1

g/l

0.34

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

254

1155

1.15

1.29

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

109

460

1.24

1.28

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

316

1.29

1.28

1.4

1.2

93.4

298.6

u/l

0.70

220

(3000285) Sodium [Moles/volume] in Blood

317

1.28

1.25

1.2

1.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.81

1.25

2.3

2.2

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

112

1.49

1.23

1.0

0.1

0.2

u/ml

0.63

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

125

1.46

1.23

1.3

1.7

170.8

177.2

ug/g

0.09

109

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

160

1.40

1.22

1.5

1.7

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

531

0.80

1.21

4.4

5.6

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

348

1624

1.12

1.20

6.2

6.8

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

2.05

1.18

1.1

1.0

—

(3032641) Amino acids panel - Urine

2.20

1.18

1.3

1.6

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

1.78

1.18

1.5

1.3

0.6

0.7

u/field

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

861

4192

1.07

1.18

1.2

1.4

7.4

7.0

mmol/l

2.22

616

3001

(3006969) Lambda light chains [Mass/volume] in Urine

1.71

1.18

1.1

0.0

0.1

g/l

—

(3024316) Viscosity of Plasma

127

1.44

1.15

1.5

1.9

1.8

1.6

mpas

0.36

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

189

1.35

1.15

3.7

4.8

—

(3007700) Barley IgE Ab [Units/volume] in Serum

136

1.42

1.14

1.1

1.0

0.4

11.1

u/ml

0.49

(3003843) Paprika IgE Ab [Units/volume] in Serum

1.61

1.13

1.0

0.1

u/ml

0.03

(3015350) Toxocara sp Ab [Presence] in Serum

2.09

1.12

1.0

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

1.63

1.12

7.2

8.8

40.7

44.9

0.26

(3019174) dRVVT (LA screen)

258

1.29

1.12

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

172

1.37

1.12

1.4

1.3

356.8

314.0

umol/24h

0.66

172

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

208

1.33

1.12

1.1

—

(3042301) Urate [Moles/volume] in Synovial fluid

1.74

1.12

1.0

538.8

358.5

umol/l

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

159

1.38

1.11

1.5

1.8

—

(3027874) Urate [Moles/volume] in Urine

1.55

1.10

1.1

1.7

9.1

mmol/l

0.50

(3043614) Bacteria identified in Aspirate by Culture

2.61

1.10

1.0

1.1

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

2.28

1.09

1.0

1.6

—

(3044009) aPTT.lupus sensitive (LA screen)

274

1.28

1.07

1.2

—

(3022689) Creatine [Moles/volume] in Urine

164

735

1.16

1.07

1.3

1.5

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.53

1.05

1.0

0.1

u/ml

0.07

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

190

0.69

1.04

1.0

1.3

—

(3026470) Cobalt [Mass/volume] in Blood

316

1487

1.11

0.99

1.9

2.0

3.3

3.8

ug/l

0.64

271

1321

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.74

0.99

1.0

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.70

0.99

1.1

1.2

—

(3022475) Manganese [Moles/volume] in Blood

163

1.34

0.98

1.2

1.3

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

124

1.39

0.94

1.6

1.8

206.8

202.5

ng/l

0.09

104

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

2.24

0.93

1.0

1.1

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

2.24

0.93

1.0

1.1

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

2.24

0.93

1.2

1.0

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

2.24

0.93

1.2

1.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.53

0.92

7.2

9.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

337

1.22

0.91

2.3

2.6

71.3

70.5

pmol/l

0.02

295

(3007542) Rye IgE Ab [Units/volume] in Serum

152

1.34

0.90

1.1

1.0

0.2

12.8

u/ml

0.51

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

247

1434

0.90

0.89

1.1

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

456

2197

1.08

0.89

1.8

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

1.58

0.89

1.0

14.3

7.2

u/ml

0.54

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

194

1.29

0.87

4.6

5.3

—

(40765096) Chromosome analysis panel by Banding

161

735

1.14

0.87

1.2

1.1

—

(3025577) Chromium [Mass/volume] in Blood

306

1453

1.10

0.85

2.0

2.1

2.2

2.3

ug/l

0.30

247

1224

(3009677) Dengue virus Ab [Presence] in Serum

118

1.37

0.84

1.1

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

110

1.38

0.81

11.9

8.7

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

1.42

0.80

1.0

1.1

0.2

g/l

0.22

(3041184) Isoniazid [Presence] in Urine

1.80

0.80

2.8

2.7

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

2.37

0.79

1.0

1.2

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

2.37

0.79

1.0

1.1

23.4

36.4

umol/l

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.81

0.79

1.1

1.0

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

154

709

1.13

0.76

1.9

2.0

31.7

38.8

u/l

0.26

141

646

(3020356) Listeria sp identified in Specimen by Organism specific culture

213

0.76

0.75

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.68

0.75

1.0

1.1

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

218

1.24

0.74

1.3

1.2

1.5

ml/s/173m2

0.38

130

(3045177) Copper [Moles/volume] in Urine

1.65

0.74

1.1

0.1

0.5

umol/l

—

(4038314)

276

0.79

0.73

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

114

682

0.87

0.72

1.2

1.3

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

290

1.21

0.72

1.0

0.1

u/ml

0.57

156

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

129

591

1.14

0.70

2.9

2.5

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

126

0.70

0.68

1.0

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

584

2877

1.06

0.67

1.3

1.4

13.0

11.7

mmol/l

2.26

186

597

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

418

1.16

0.67

1.2

1.3

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

1.86

0.67

1.4

1.1

30.4

31.1

nmol/24h

—

(40759632) Porphyrins [Mass/mass] in Stool

1.74

0.65

1.4

1.0

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

342

1658

1.08

0.64

1.3

1.4

5.9

5.5

mmol/l

3.71

321

1580

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.54

0.64

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.57

0.63

2.5

3.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

973

4869

1.04

0.62

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

431

1.15

0.62

1.3

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

139

1.28

0.62

10.3

10.4

266.0

240.9

e6/l

0.06

103

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

296

1.18

0.61

1.0

0.1

2.5

u/ml

0.74

155

(3007456) Orange IgE Ab [Units/volume] in Serum

1.40

0.59

1.1

1.0

0.1

0.2

u/ml

0.46

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.54

0.59

1.2

1.1

—

(3048879) Bone marrow aspiration report

158

744

1.11

0.58

1.4

1.9

—

(3028468) Fragments [Presence] in Blood by Light microscopy

1.74

0.58

1.0

2.4

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

178

1.23

0.58

1.0

1.1

8.7

u/ml

0.00

124

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

116

0.72

0.58

1.1

1.0

0.2

u/ml

—

(40765089) Chromosome analysis panel - Blood by G-banded

192

1095

0.91

0.57

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

1.46

0.56

1.1

1.2

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.58

0.55

1.5

1.1

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

1.47

0.54

1.1

1.0

4.7

0.5

u/ml

—

(3006598) pH of Arterial cord blood

0.58

0.54

1.0

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

199

1.21

0.54

2.6

2.1

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

223

1.19

0.54

2.5

2.3

56.7

61.7

0.37

137

(3003740) Influenza virus B Ag [Presence] in Specimen

969

4871

1.04

0.53

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

274

1.16

0.49

1.0

0.6

0.5

u/ml

0.04

154

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.32

0.48

1.1

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.58

0.48

1.0

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

192

925

1.08

0.47

1.2

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

192

0.82

0.47

1.1

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

198

1.19

0.46

1.0

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

103

1.27

0.46

1.0

0.1

u/ml

0.12

(3013762) Body weight Measured

108

1.26

0.45

1.0

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

394

1.13

0.45

3.5

3.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

119

563

1.10

0.44

1.3

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

267

1307

1.07

0.44

30.5

27.5

126.2

115.3

ug/l

1.55

217

1096

(3010937) Rubella virus Ab [Presence] in Serum

196

0.82

0.44

1.0

1.1

—

(3004959) Base excess in Arterial cord blood by calculation

0.61

0.44

1.0

1.2

—

-1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

119

564

1.10

0.43

1.3

1.1

—

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

0.00

0.43

0.0

2.4

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

150

0.80

0.43

1.1

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.43

0.0

5.3

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

0.43

0.0

1.2

—

(3003577) Lead [Moles/volume] in Blood

229

1.16

0.43

1.3

1.5

0.3

0.2

umol/l

0.40

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

119

565

1.10

0.42

1.2

1.1

—

(3021374) Sirolimus [Mass/volume] in Blood

1.39

0.42

12.3

9.3

8.6

7.3

ug/l

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.43

0.42

1.0

1.1

860.0

2249.0

titre

2.64

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

0.42

0.0

1.0

—

(3049233) Organic acids panel - Urine

1.53

0.42

1.2

1.0

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

167

1.19

0.41

1.0

1.1

1.6

1.1

u/ml

0.16

118

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

120

0.78

0.41

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

148

1.20

0.40

3.1

3.4

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

153

1.19

0.40

1.4

1.5

21.8

21.9

mmol/l

0.07

104

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

105

498

1.10

0.39

1.8

1.7

4.0

ug/l

1.39

314

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.34

0.38

2.1

2.5

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.25

0.38

1.0

1.1

—

(40758292) HTLV I+II Ab panel - Serum

501

0.91

0.37

1.3

1.4

—

(3009992) Blasts/100 cells in Bone marrow

1.49

0.37

1.0

2.0

23.5

10.4

—

(3022670) pH of Venous cord blood

0.67

0.34

1.0

1.1

—

(3049242) von Willebrand panel - Platelet poor plasma

1.24

0.34

1.2

1.7

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

861

4613

0.97

0.32

1.3

3.2

3.8

ug/l

1.42

760

4185

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

177

1.15

0.31

2.4

2.3

11.7

16.0

0.55

(3024471) HLA-A [Type]

185

1023

0.94

0.31

1.0

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

0.80

0.31

1.1

1.0

0.4

1.0

u/ml

—

(3029612) Listeria sp Ab [Titer] in Serum

1.28

0.30

1.4

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

351

1904

0.96

0.29

1.7

2.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.34

0.28

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

147

0.85

0.27

1.2

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.80

0.27

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.22

0.27

2.4

3.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

167

824

1.06

0.27

1.2

1.1

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.27

0.26

1.0

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

330

1.09

0.25

1.4

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.21

0.25

1.4

1.7

167.4

118.3

ug/l

0.33

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.28

0.23

3.6

4.4

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

388

1.08

0.23

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

155

0.87

0.22

1.0

—

(43054952) inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.22

0.0

10.8

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.22

0.0

1.2

—

2.6

—

(3013862) HLA-DP [Type]

105

0.84

0.22

1.0

—

(46236302) HLA-C [Type] by High resolution typing

105

0.84

0.22

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

105

0.84

0.22

1.5

1.3

—

(3032642) Schistosoma sp Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

(3006407) Chromogranin A [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.3

—

153.1

—

(3009871) Measles virus Ab [Titer] in Serum

199

995

1.04

0.21

1.7

1.6

—

(3024932) HLA-DR beta [Type]

184

1002

0.96

0.21

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1155

6121

0.98

0.20

1.8

1.6

—

(3003157) Bacteria [#/volume] in Mother's milk

0.82

0.19

6.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

169

0.90

0.19

5.8

5.3

—

(40763590) HLA-DQ beta [Type]

103

0.86

0.18

1.0

—

(40760410) HLA-B [Type] by High resolution

103

0.86

0.18

1.0

—

(40760409) HLA-A [Type] by High resolution

103

0.86

0.18

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

403

1.06

0.18

11.7

6.3

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

231

1.08

0.17

1.0

7.5

4.0

u/ml

—

(3026250) Tacrolimus [Mass/volume] in Blood

251

1351

0.97

0.17

37.1

36.0

7.7

7.4

ug/l

1.98

225

1227

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

141

1.11

0.17

1.1

—

(3018133) Calcium [Moles/volume] in Urine

404

1.06

0.17

1.7

1.8

2.4

2.7

mmol/l

1.00

360

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

313

1.07

0.16

1.6

1.4

72.4

71.1

0.13

256

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

654

3351

1.02

0.16

1.2

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

1.17

0.16

1.3

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

167

1.09

0.15

3.8

2.6

22.7

13.8

0.83

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.14

0.13

1.2

1.3

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.81

0.13

1.1

1.4

1.5

2.1

mmol/24h

—

(3032868) Hemoglobin electrophoresis panel in Blood

283

0.94

0.13

1.5

1.6

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

261

1.06

0.12

1.1

1.2

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

110

0.90

0.12

1.1

1.0

0.2

0.4

u/ml

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

692

3563

1.01

0.11

2.4

2.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

6145

32184

1.00

0.11

1.4

—

(3042733) HLA Ab [Presence] in Serum

195

1043

0.98

0.11

4.4

5.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

206

1.06

0.11

2.8

2.5

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

120

1.09

0.10

1.0

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

232

1.06

0.10

1.0

1.1

—

(4281824)

533

2743

1.01

0.10

1.1

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

171

1.07

0.10

1.1

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

1.13

0.10

1.2

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

1.09

0.10

1.0

3.0

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

1.09

0.10

1.0

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.90

0.08

1.0

1.1

—

(40762814) Titanium [Mass/volume] in Blood

426

0.97

0.08

2.1

2.3

4.0

3.8

ug/l

0.05

144

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

342

1.04

0.08

7.1

7.8

0.3

umol/l

0.26

306

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.10

0.08

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.10

0.08

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.10

0.08

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.10

0.08

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.10

0.08

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.10

0.08

2.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

139

0.94

0.07

1.0

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

107

1.07

0.07

1.0

1.1

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.13

0.07

1.0

1.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.08

0.06

1.8

2.0

—

(40768446) Kidney Pathology biopsy report

230

1183

1.01

0.06

1.6

1.7

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.90

0.05

4.5

5.3

0.2

mmol/l

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

130

666

1.02

0.05

8.5

8.6

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

233

1203

1.01

0.04

1.2

1.1

—

(40758358) Immune stain study

109

1.05

0.04

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

110

582

0.99

0.03

8.7

8.6

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

240

1262

0.99

0.03

1.2

1.1

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

1.06

0.02

1.0

0.0

0.2

u/ml

—

(3018291) Platelet Ab [Presence] in Serum

1.09

0.02

1.1

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

183

1.03

0.02

1.0

1.1

50.3

28.9

u/ml

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

183

1.03

0.02

1.0

1.1

35.4

21.8

u/ml

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

443

0.99

0.01

6.7

7.1

—

(3051101) Glucose [Moles/volume] in Cord blood

455

1.01

0.01

5.7

5.6

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

153

1.02

0.00

1.0

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

109

572

0.99

0.00

2.6

118.1

96.8

ng/l

0.17

290

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.03

0.00

1.2

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

110

1.00

0.00

17.0

15.0

—

(3025315) Body weight

253

1.01

0.00

4.7

4.5

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.02

0.00

1.8

1.9

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

115

1.00

0.00

1.3

1.2

—

(3022912) Hexacarboxylporphyrin [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

1.01

0.00

1.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.99

0.00

1.1

1.3

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.98

0.00

1.0

1.3

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.99

0.00

1.1

1.3

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: OTHER_ANTIDEPRESSANTS – Other antidepressants

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Other antidepressants

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Other antidepressants (OTHER_ANTIDEPRESSANTS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints